TABLE OF CONTENTS - EPHAR 2016 · Plenary Lecture, Hall A (13:30-14:30): Purinergic signaling in adult neural progenitor cell functions: Experimental basis and possible therapeutic

1

3

TABLE OF CONTENTS

Welcome 4

Committees 5

Sponsorships 7

Floor plan 8

Scientific programme 9

Paralel meetings 37

Poster sessions 41

Author index 65

4

Dear friends and colleagues,

It is a great pleasure for me to welcome you to Istanbul, Turkey for the 7th European Congress of Pharmacology in 26-30 June 2016. The Congress is hosted by the Turkish Pharmacological Society. The members of the society, the Local Organising Committee and the Scientific Committee took great care to design a programme that combines hot topics in pharmacology. All the announcements are available through the congress web page www.ephar2016.org. After the congress the website will be accessed from www.tfd.org.tr/ephar/2016 in order to make it available for long term.

Turkish Pharmacological Society, established in 1966, is a rapidly expanding community looking forward to having international scientific and social collaborations. Our 23rd national meeting, held in Ankara between 7-10 September 2015 welcomed more than 300 delegates. 2016 will be 50th anniversary of our society, and it is going to be a great pleasure for us to celebrate both events together in Istanbul.

The 7th European Congress of Pharmacology is taking place in Military Museum and Cultural Centre, located in the heart of the city. This modern congress centre with easy transportation offers convenient facilities such as meeting rooms for ongoing parallel sessions allowing you to select your favourite topics, exhibition hall for poster sessions and companies, and networking places to meet with your colleagues.

Istanbul is the biggest city in Turkey, located in the north-western part of the country, with a pleasant climate in June. Istanbul is a real must see destination with many unique features, easily accessible by hundreds of direct flights from many countries. It is the only city in the world to connect two continents-Europe and Asia. Istanbul, which has been a capital for centuries, embraces many historical and cultural beauties of Turkey including ancient and modern attractions.

On behalf of the Organising Committee, I welcome you to Istanbul for a great meeting to exchange knowledge between basic and clinical fields of pharmacology throughout the World and to share good times.

We hope EPHAR 2016 Istanbul will always be in your best memories!

Öner SüzerCongress Chair EPHAR 2016

5

CONGRESS CHAIR

Öner SÜZER İstanbulUniversity,İSTANBUL

SCIENTIFIC SECRETARIES

B. Sönmez UYDEŞ DOĞAN İstanbulUniversity,İSTANBUL

Nezahat Tuğba DURLU-KANDİLCİ HacettepeUniversity,ANKARA

INTERNATIONAL SCIENTIFIC ADVISORY BOARD

Mladen BOBAN PresidentofCroatianPharmacologySociety, UniversityofSplit,CROATIAGuiseppo CIRINO SecretaryGeneralofItalianSocietyforPharmacology, UniversityofNaples,ITALYPaulo CORREIA-DE-SÁ PresidentofPortuguesePharmacologicalSociety, UniversidadedoPorto,PORTUGALMarek DROZDZIK PresidentofPolishPharmacologicalSociety, PomeranianMedicalUniversity,POLANDMaria Jesús Sanz FERRANDO PresidentofSpanishSocietyofPharmacology, UniversityofValencia,SPAINMarkus FORSBERG PresidentofFinnishPharmacologicalSociety, UniversityofEasternFinland,FINLANDLjiljana GOJKOVIC-BUKARICA PresidentofSerbianPharmacologicalSociety, UniversityofBelgrade,SERBIAThomas GRIESBACHER PresidentofAustrianPharmacologicalSociety, GrazUniversity,AUSTRIALutz HEIN PresidentofGermanSocietyforPharmacology, UniversityofFreiburg,GERMANYBaiba JANSONE PresidentofLatvianSocietyofPharmacology, UniversityofLatvia,LATVIAMojca KRZAN PresidentofSlovenianPharmacologicalSociety, LjubljanaUniversity,SLOVENIAFrancesca LEVI-SCHAFFER ChairofIUPHARImmunopharmacologySection, TheHebrewUniversityofJerusalem,ISRAELClaus Juul LØLAND HeadofPharmacologySectionofDanishSocietyforPharmacology, ToxicologyandMedicalChemistry,UniversityofCopenhagen,DENMARKRoos MASEREEUW PresidentofDutchSocietyforPharmacology, UtrechtUniversity,TheNETHERLANDSBarbara MCDERMOTT Vice-PresidentofBritishPharmacologicalSociety, Queen’sUniversity(Belfast),UKEeva MOILANEN PastPresidentofEPHAR,UniversityofTampere,FINLANDAndreas PAPAPETROPOULOS PresidentofHellenicSocietyofBasicandClinicalPharmacology, UniversityofAthens,GREECE

COMMITTEES

6

Sergey SEREDENIN PresidentofRussianPharmacologicalSociety, ZakusovInstituteofPharmacology,RUSSIATabassome SIMON PresidentofEuropeanAssociationforClinicalPharmacologyand Therapeutics,PierreandMarieCurieUniversity(UPMC),FRANCEBeata SPERLAGH PresidentofHungarianSocietyforExperimentalandClinical Pharmacology(HSECP),HungarianAcademyofSciences, HUNGARYCarl-Olav STILLER PresidentofSwedishSocietyforPharmacology, ClinicalPharmacologyandTherapeutics,KarolinskaInstitute, SWEDENJuan TAMARGO ChairofScientificCommitteeofofEPHAR2012Congress, ComplutenseUniversity(Madrid),SPAINMeral TUNCER PastPresidentofTurkishPharmacologicalSociety, BaşkentUniversity,TURKEYJohan Van de VOORDE TreasurerofBelgianSocietyofFundamentalandClinicalPhysiology andPharmacology,GentUniversity,BELGIUM

LOCAL ORGANIZING COMMITTEE

Eyüp S. AKARSU AnkaraUniversity,ANKARA

Feyza ARIClOĞLU MarmaraUniversity,İSTANBUL

Remzi ERDEM BaşkentUniversity,ANKARA

Kevser EROL EskişehirOsmangaziUniversity,ESKİŞEHİR

Mehmet Zafer GÖREN MarmaraUniversity,İSTANBUL

Bülent GÜMÜŞEL HacettepeUniversity,ANKARA

B. Alper İSKİT HacettepeUniversity,ANKARA

Yusuf Cem KAPLAN KatipÇelebiUniversity,İZMİR

Mehmet MELLİ AnkaraUniversity,ANKARA

K. Esra NURULLAHOĞLU ATALIK NecmettinErbakanUniversity,KONYA

Yeşim TUNÇOK DokuzEylulUniversity,İZMİR

Bahar TUNÇTAN MersinUniversity,MERSİN

Pınar YAMANTÜRK ÇELiK İstanbulUniversity,İSTANBUL

Ersin YARIŞ KaradenizTechnicalUniversity,TRABZON

7

SPONSORSHIPS

Golden Sponsor

Societies / Scientific Organisations

Commercial Sponsors and Exhibitors

8

FLOOR PLAN

Scientific Program

BOOTH PLAN

1.

2.

3.

4. EPHAR 2020

5. Turkish Pharmacological Society

6.

7. AD Instruments

8. Commat

9. Elsevier

10. Ugo Basile

11. Ugo Basile

9

Scientific ProgramScientific Program

10

Theprogrammeincludesthefollowingsessions:Aplenary sessionisasessionwithnocontemporaryparallel,withinvitedlecturersandnooralcommunications.Thesesessionslastfor60minutes.Amain sessionisorganizedbyanationalpharmacologicalsocietyorasponsorinconsultationwiththeScientificCommittee.Theyruninparallelandwithinvitedlecturersandelevatedtalkschosenbytheorganizersofthesessionamongrelevantfreesubmissions.Amainsessionlastsfor150minutes(plusa30minutecoffeebreakinsidethesession).Anoral presentation sessioniscomposedofavariablenumberofselectedoralcommunicationsfromthesamefield.Thissessionlasts90minutes(maximum).Aworkshopisasessionorganizedbyanexternalorganization.

Oral presentationsC001-C0120referoralpresentations.C001-C036areelevatedtalkswhichareincludedinmainsessions.C037-C064willbepresentedonoralpresentationsessionsatMonday,27thJune2016between13:30-15:00(oralsessions1-5,hallsA-E).C064-C092willbepresentedonoralpresentationsessionsatTuesday,28thJune2016between15:00-16:30(oralsessions6-10,hallsA-E).C093-C120willbepresentedonoralpresentationsessionsatWednesday,29thJune2016between15:00-16:30(oralsessions11-15,hallsA-E).

Poster presentationsP001-P276referposterpresentations.EPHARPosterAwardWinnerposterwillbepresentedatallpostersessiondays.P001-P092willbepresentedatpostersessionday1,Monday,27thJune2016between08:30-17:30(PosterHall)P093-P183willbepresentedatpostersessionday2,Tuesday,28thJune2016between08:30-17:30(PosterHall)P184-P276willbepresentedatpostersessionday3,Wednesday,29thJune2016between08:30-17:30(PosterHall)

SCIENTIFIC PROGRAMME

11

Sunday, 26th June 2016OpeningSession,HallA

Monday, 27th June 2016MainSessions(09:00-12:00)HallA:SmallmoleculesinhibitorsofionchannelsinchronicpainstatesHallB:DifferentimmunopharmacologicalapproachestotreatallergicdiseasesHallC:EPA/DHA:Cardiovascularhealthandomega-3long-chainPUFAsHallD:Targetingcodingandnon-codingRNAsinpharmacologicalresearch

Lunch&PosterViewing(12:00-13:30)

OralPresentations(13:30-15:00)Session1,HallA:Neuropharmacology/Psychopharmacology;ObesityandMetabolicDiseases(C037-C042)Session2,HallB:CardiovascularPharmacology(C043-C048)Session3,HallC:ClinicalPharmacology(C049-C053)Session4,HallD:DrugSafetyandToxicology(C054-C058)Session5,HallE:Neuropharmacology/Psychopharmacology(C059-C064)

PlenaryLectureHallA(15:30-16:30):miRNAsaspotentialtherapeutictargetsincardiovasculardisorders

Tuesday, 28th June 2016MainSessions(09:00-12:00)HallA:HowtoimprovetranslationfromanimalstohumansHallB:EmergingtherapeutictargetsinchronicpainandinflammationHallC:Calciumsignallinginducedbysphingosine-1-phosphateandotheragonistsinurogenitaltractHallD:Signallingpathwaysinvascularfunctionanddysfunction


PlenaryLecture,HallA(13:30-14:30):Purinergicsignalinginadultneuralprogenitorcellfunctions:Experimentalbasisandpossibletherapeuticsignificance

OralPresentations(13:30-15:00)Session6,HallA:Neuropharmacology/Psychopharmacology(C065-C069)Session7,HallB:CardiovascularPharmacology(C070-C075)Session8,HallC:PharmacokineticsandDrugMetabolism(C076-C081)Session9,HallD:ReceptorsandCellSignalling(C082-C087)Session10,HallE:DrugDiscovery,DevelopmentandEvaluation(C088-C092)

MEETING AT A GLANCE

12

Wednesday, 29th June 2016MainSessions(09:00-12:00)HallA:DopaminesignalinginhealthanddiseaseHallB:Basicandtranslationalpharmacologyofhydrogensulfide:moleculartargetsandtargeteddiseasesHallC:Traceamineassociatedreceptors(TAARs):apromisingtargetforpharmacotherapies?HallD:MolecularclocksandchronopharmacologyHallE:ORPHEUSplatform:“BestPracticesforHighResearchStandardsandPhDStudentstraininginResponsibleResearch”


PlenaryLecture,HallA(13:30-14:30):Poly(ADP-ribose)polymerase:pathomechanismsandtherapeuticopportunities

OralPresentations(13:30-15:00)Session11,HallA:PainandInflammation;Gasotransmitters(C093-C098)Session12,HallB:CancerChemotherapy;RespiratoryPharmacology;GenitourinaryandReproductivePharmacology(C099-C104)Session13,HallC:GastrointestinalPharmacology;RationalDrugUse(C105-C110)Session14,HallD:DrugDiscovery,DevelopmentandEvaluation;DrugsforInfectiousDiseases(C111-C116)Session15,HallE:Miscellaneous(C117-C120)

Thursday, 30th June 2016MainSessionsHallA:Targetinginflammationindisease(09:00-12:00)HallB:EuropeanRegisteredPharmacologistProject(09:00-10:30)HallB:EJPEducationalSeminar(11:00-12:00)HallC:Newinsightsinneuropsychiatricdisorders:models&moleculeswiththerapeuticpotential(09:00-12:00)HallD:Biasedsignaling-farbeyondarrestin(09:00-10:30)LocalworkshopHallE:RationalDrugUse(11:00-12:00)Endofcongress:12:00

MEETING AT A GLANCE

13

Sunday, 26th June 2016Opening Session, Hall A18:00-20:00

18:00 OpeningCeremony18:30 WelcomeReception;TurkishPharmacologicalSociety50thanniversary20:00 Endofopeningsession

Monday, 27th June 201609:00-12:00 Main Session Monday, 27th June 2016, Hall A:

Small molecules inhibitors of ion channels in chronic pain states(OrganizedbyBritishPharmacologicalSociety)Organizersandchairs:EdwardStevens(PfizerNeuroscienceandPainResearchUnit,Cambridge,UK)GaryStephens(UniversityofReading,UK)

09:00 IntroductiontothesessionGaryStephensUniversityofReading,UK

09:15 SmallmoleculeinhibitorsofNaV1.7voltage-gatedsodiumchannelsEdwardStevensPfizerNeuroscienceandPainResearchUnit,UK

09:45 Elevatedtalk(C001):Geneexpressionprofileofsodiumchannelsubunitsintheanteriorcingulatecortexduringexperimentalpaclitaxel-inducedneuropathicpainWilliasMasochaKuwaitUniversity,KUWAIT(Authors:WilliasMasocha)

10:00 RoleofM-typeK+channelsinacuteandchronicpainNikitaGamperUniversityofLeeds,UK

10:30 Automatedpatchclampionchanneltechnologyinchronicpaindrugdiscovery-panaceaorpaucity?DamianBellCharlesRiverLaboratories,UK

11:00 TRPchannelsinpainLucyDonaldsonUniversityofNottingham,UK

11:30 Elevatedtalk(C002):TargetingchangesininhibitorysignallinginchronicpainWendyL.ImlachTheUniversityofSydney,AUSTRALIA(Authors:WendyLImlach,MacdonaldJChristie)

12:00 Endofsymposium


14

09:00-12:00 Main Session Monday, 27th June 2016, Hall B: Different immunopharmacological approaches to treat allergic diseases(OrganizedbyDanone-NutriciaResearch,Utrecht,theNetherlandsandIUPHAR/Immunopharmacology)Organizersandchairs:FrancescaLevi-Schaffer(TheHebrewUniversityofJerusalem,ISRAEL)AlettaKraneveld(UtrechtUniversity,TheNETHERLANDS)

09:00 Pro-resolvingmediators:potentialnewtreatmentfortheallergyandasthmaOliverHaworthBartsandtheLondonSchoolofMedicine&Dentistry,UK

09:30 MicrobiomemanipulationforthemanagementofallergicdisordersJohanGarssenUtrechtUniversity,TheNETHERLANDS

10:00 ActivateinhibitionandinhibitactivationofmastcellsandeosinophilswithantibodiestotreatallergicdiseasesFrancescaLevi-SchafferTheHebrewUniversityofJerusalem,ISRAEL

10:30 Coffeebreak11:00 Elevatedtalk(C003):Novelmechanismofactionwiththerapeuticpotential:the

chemokineneutraligandsforasthmaNellyFrossardUniversitédeStrasbourg,FRANCE(Authors:NellyFrossard,FrançoisDaubeuf,DominiqueBonnet,DayanaAbboud,VirgileBeckaert,AliOuadi,PatriceMarchand,DavidBrasse,MarcelHibert,JeanLucGalzi)

11:15 Elevatedtalk(C004):ProblemsofstandardizingspecificactivityofallergenproductsViacheslavIvanovMinistryofHealthoftheRussianFederation,RUSSIA(Authors:ViacheslavIvanov,ViacheslavMosyagin,VladimirBondarev,YuryOlefir)

11:30 Elevatedtalk(C005):InvolvementofCXCR6/CXCL16axisinplatelet-leukocyteadhesiontothedysfunctionalarterialendotheliuminCOPDpatientsPatriceMarquesUniversityofValencia,SPAIN(Authors:PatriceMarques,AidaCollado,CristinaRius,PaulaEscudero,CruzGonzález,EmilioServera,LauraPiqueras,MariaJesusSanz)

11:45 Elevatedtalk(C006):Galectin-9promotesALDHactivityindendriticcellstosupportthedifferentiationofTregcellsinvitroAlettaKraneveldUtrechtUniversity,TheNETHERLANDS(Authors:SanderDeKivit,AtanaskaIKostadinova,JoannKerperien,MaryEMorgan,LeonMKnippels,AlettaDKraneveld,JohanGarssen,LinetteWillemsen)


SCIENTIFIC PROGRAMMEMonday, 27th June 2016

15

09:00-12:00 Main Session Monday, 27th June 2016, Hall C: EPA/DHA: Cardiovascular health and omega-3 long-chain PUFAs (OrganizedbyGOED,GlobalOrganizationforEPAandDHAomega3s)Organizersandchairs:GerardBannenberg(GOED(GlobalOrganizationforEPAandDHAomega3s),USA)AliMüderrisoğlu(SifarPharmaceuticals,TURKEY)

09:00 Acurrentviewoftherelationoflipidintaketocardiovascularhealth,includingthebioavailabilityofvariouslipidformsRobWinwoodDSMNutritionalProducts,SWITZERLAND

09:30 Overviewoftheevidenceforomega-3LCPUFAandcardiovascularhealthPhilipCalderUniversityofSouthampton,UK

10:00 Elevatedtalk(C008):NiacinandoliveoilpromotetheskewingtoM2phenotypeinbonemarrow-derivedmacrophagesofmicewithmetabolicsyndromeMariaCNaranjoInstitutodelaGrasa,CSIC,SPAIN(Authors:MariaCNaranjo,SergioMontserratDeLaPaz,SergioLopez,RocioAbia,FranciscoJ.g.Muriana,BeatrizBermudez)

10:30 Coffeebreak11:00 CYP450epoxygenasesassourcesofprotectiveomega-3lipidmediatorsinvascular

inflammationandresolutionDavidBishop-BaileyUniversityofLondon,UK

11:30 Omega-3Index-whytheomega-3statusmattersClemensVonSchackyUniversityofMunich,GERMANY

12:00 Endofsymposium09:00-12:00 Main Session Monday, 27th June 2016, Hall D:

Targeting coding and non-coding RNAs in pharmacological research(OrganizedbyTurkishPharmacologicalSociety)Organizersandchairs:BaharTunçtan(MersinUniversityFacultyofPharmacyDepartmentofPharmacology)

09:00 TargetingmiRNAsinthetreatmentofcardiovascularandrenaldiseasesBaharTunçtanMersinUniversity,TURKEY


16

09:30 Targetingthestore-operatedcalciumentryMetinerTosunİzmirUniversityofEconomics,TURKEY

10:00 miRNAsasbiomarkersforearlydiagnosisofcertaindiseasesMehmetSamiSerinMersinUniversity,TURKEY

10:30 Coffeebreak11:00 Elevatedtalk(C009):TheeffectofS-nitrosogluthatione(GSNO)inaratmodelof

isoproterenolinducedmyocardialinfarctionDenizKaleliDurmanİstanbulUniversity,TURKEY(Authors:DenizKaleliDurman,UğurAksu,DuyguTerzioğlu,IşıkIkbalBarış,DilekYılmazBayhan,B.SönmezUydeşDoğan)

11:15 Elevatedtalk(C010):ProtectiveandtherapeuticeffectsofdoxycyclineagainstrenalischemiareperfusioninjuryinratsMustafaSağırGaziosmanpasaUniversity,TURKEY(Authors:MustafaSağır,HakanParlakpinar,FatihOguz,AlaaddinPolat,GulPelinOdabasi)

11:30 Elevatedtalk(C011):PYK2asatherapeutictargetformyocardialinfarctionSofiaIrisBibliNationalandKapodistrianUniversityofAthens,GREECE(Authors:SofiaIrisBibli,ZongminZhou,SvenZukunft,BeateFisslthaler,IoannaAndreadou,CsabaSzabo,PeterBrouckaert,IngridFleming,AndreasPapapetropoulos)

11:45 Elevatedtalk(C012):Theeffectofbeta3-ARsonNa+/K+-ATPaseincardiachypertrophyGizemKaykiMutluAnkaraUniversity,TURKEY(Authors:GizemKaykiMutlu,EbruAriogluInan,IremKaraomerlioglu,VecdiMelihAltan)

12:00 Endofsymposium13:30-15:00 Oral Presentation Session 1, Monday, 27th June 2016, Hall A

Neuropharmacology/Psychopharmacology;ObesityandMetabolicDiseasesChairs: CharisLiapi(NationalandKapodistrianUniversityofAthens,Greece) AhmetUlugöl(TrakyaUniversity,Turkey)

13:30 C037:UnilateralAAV-mediatedalpha-synucleinoverexpressionmodelofParkinsondisease’stostudymotorandcognitivedysfunctionBanuCahideTel,SevgiUğurMutluay,ElifÇınar,GülYalçınÇakmaklı,EsenSaka,AyşeUlusoy,BülentElibol

13:45 C038:Continuityofantipsychoticprescriptioninahomelesscohort:resultsofarandomizedcontrolledtrialStefanieNadyaRezansoff,JulianMylesSomers,AkmMoniruzzaman


17

14:00 C039:TheeffectofacutestressandtheroleofmineralocorticoidandglucocorticoidreceptorspresentintheprefrontalcortexinthememoryextinctionlearningJessicaRosa,DanielaLescanoMartinsUliana,LeandroAnteroDaSilva,LeonardoBarbosaMoraesResstel

14:15 C040:EffectofafunctionalfoodonthePLIR(peroxidationofleukocytesindexratio)duringpost-prandialstressinhealthysubjectsHusseenManafikhi,IlariaPeluso,RaffaellaReggi,YaroslavaLonghitano,ChristianZanza,MauraPalmery

14:30 C041:Cardiacremodelingalterationsincholine-deprivedrats:AnoverviewCharisLiapi,AthinaStrilakou,AhmedAlHumadi

14:45 C042:Expressionoftrpv1receptorsincreasedinhippocampusfollowingpentylenetetrazoleinducedkindlinginmaleratsAliShamsizadeh,FarangisFatehi,ImanFatemi,GholamhosseinHassanshahi,MohammadKazemiArababadi

13:30-15:00 Oral Presentation Session 2, Monday, 27th June 2016, Hall B CardiovascularPharmacologyChairs:MaríaJesusSanz(UniversityofValencia,Valencia,Spain) BuketReel(EgeUniversity,Turkey)

13:30 C043:PhysiologicallyrelevantconcentrationsofhydrogensulfidenegativelyregulateplateletaggregationinvitroandinvivoMichaelEmerson,FrancescaRauzi,EricaSmyth,MilosFilipovic,MarkEWood,MatthewWhiteman

13:45 C044:Abdominalaorticaneurysm(AAA)formationandmononuclearcelladhesioninducedbyangiotensinIIarepartlydependentonCXCR6/CXCL16axisAidaCollado,PatriceMarques,CristinaRius,ElenaDomingo,PaulaEscudero,LauraPiqueras,MaríaJesusSanz

14:00 C045:ThenitricoxidemediatedeffectsofnebivololincardiorenalsyndromeGuldemMercanoglu,CaglarMacit,SemenYesil,BurakPamukcu,NurhasSafran,HafizeUzun,AyferYalcin,FehmiMercanoglu

14:15 C046:CardioprotectiveEffectofCyclosporinAAgainstDoxorubicinCardiotoxicityMeryemŞeydaKaya,MeralErdinç,IlkerKelle,HasanAkkoç,EmreUyar,ZeynepErdoğmuşÖzgen,LeventErdinç

14:30 C047:DoxycyclineimprovestheimpairedcontractileresponsesinducedbyoxidativestressinhumansaphenousveingraftsMazenSaeed,BuketReel,MehmetZuhuriArun,MehmetGuzeloglu,GokselGokce,BekirUgurErgur,CerenKorkmaz

14:45 C048:Cardioprotectiveeffectsofpharmacologicallydecreasedlong-chainacylcarnitinecontentsinexperimentalmodelsofmyocardialinfarction,atherosclerosis,anddiabetesMaijaDambrova,KristineVolska,MarinaMakreckaKuka,ElinaMakarova,JanisKuka,ReinisVilskersts,EdgarsLiepinsh


18

13:30-15:00 Oral Presentation Session 3, Monday, 27th June 2016, Hall C ClinicalPharmacologyChairs:OndrejSlanar(CharlesUniversity,CzechRepublic) BekirFarukErden(KocaeliUniversity,Turkey)

13:30 C049:Twophase1clinicalstudiesevaluatingtheeffectsoftheCYP3A4inhibitorclarithromycinandtheCYP3A4inducerrifampinonsystemicexposuretopacritinibinhealthyvolunteersSulimanAlFayoumi,SherriAmberg,HuafengZhou,LindseyMillard,JackW.Singer,MaryCampbell

13:45 C050:Patternofuseofincretin-basedmedicinesinalargesampleoftheItaliangeneralpopulationGiuseppeRoberto,FrancescoBaroneAdesi,FrancescoGiorgianni,ValeriaPizzimenti,CarmenFerrajolo,FrancescoLapi,PaoloFrancesconi,GianlucaTrifirò,ElisabettaPoluzzi,FabioBaccetti,RosaGini

14:00 C051:ABCB1andOPRM1polymorphismsaltermaternalefficacyandneonatalsafetyofremifentanilinwomenundergoingcesareansectionHanaBakhouche,PavlinaNoskova,SvatoplukSvetlik,JanBlaha,OndrejSlanar

14:15 C052:EvaluationofpositivereflectionsofactivitiesencouragingawarenessregardingrationaluseofmedicinesArzuKiroglu,VolkanAydin,AhmetAkici

14:30 C053:HomozygousfamilialhypercholestrolemiapatientwithheterozygousgenotypeofMTTPgene(rs11944752)variationdoesnotresponsetolomitapidetherapyMeralKayıkcıoglu,AslıTetikVardarli,ZuhalEroglu

14:45 C054:InvestigationofantibioticutilizationfordentalinfectionsCenkerZekiKoyuncuoglu,MehtapAydin,IpekNerimanKirmizi,MesilAksoy,FatmaIsli,AhmetAkici

13:30-15:00 Oral Presentation Session 4, Monday, 27th June 2016, Hall D DrugSafetyandToxicologyChairs:MichaelEmerson(ImperialCollegeLondon,UK) DimitriosKouvelas(AristotleUniversityofThessaloniki,Greece)

13:30 C060:TheknowledgeandattitudesofnursingstudentstowardsrationaldruguseYaseminÖzatik,UlkenTungaBabaoglu,AyseOzkaraman,SemraYigitaslan,KevserErol

13:45 C056:StudyenhancerdrugsamongfuturephysiciansinMaribor,SloveniaZigaVolgemut,JanSchmidt,KatjaJerenec,PoloncaFerk

14:00 C057:EvaluationofrenalfunctioninpatientsusingmetforminNedaTaner,EmineKaratasKocberber,CengizhanCeylan,BarkınBerk


19

14:15 C058:UrinaryN-acetylatedcysteine-disulfidesasindicatorsofkidneydiseaseprogressioninHIV-infectedpatientsClaraGonçalvesDias,NunoRamosCoelho,LucíliaNevesDiogo,AnaRitaLemos,JuditMorello,EmíliaCarreiraMonteiro,KarinaSoto,SofiaAzeredoPereira

14:30 C059:Howmuchsignaldowegetfromspontaneousvs.solicitedadversedrugreaction(ADR)reports?DefininganADR-signalindexGulnihalOzcan,EmelAykac,NigarDemetAydinkarahaliloglu

14:45 C055:AssessmentofthecardiovascularriskprofileofantiretroviraltherapiesindependentofHIVinfectionEricaSmyth,BrianGazzard,MarkNelson,MichaelEmerson

14:00-15:00 Oral Presentation Session 5, Monday, 27th June 2016, Hall E Neuropharmacology/PsychopharmacologyChair:BirselSönmezUydeşDoğan(İstanbulUniversity,Turkey)

14:00 C061:Evaluationofworldwideuseofidarucizumabinaclinicalpracticesetting:rationaleanddesignoftheRE-VECTOsurveillanceprogrammeJoanneVanRyn,JoanneLee,FredrikGruenenfelder,MartinFeuring,KristinaZint,NilsSchoof,DeborahReardon,PeterZilles,JörgKreuzer

14:15 C062:Potassiumchannel-independenteffectsofpinacidilontheisolatedhumansaphenousveinsfromdiabeticpatientsJovanaRajkovic,MiodragPeric,RadmilaNovakovic,DuskoNezic,VladimirDjokic,VladimirZivanovic,HelmutHeinle,LjiljanaGojkovicBukarica

14:30 C063:2beta-hydroxybetulinicacid3beta-caprylate:anactiveprinciplefromeuryaleferoxsalisb.seedswithantidiabetic,antioxidant,pancreas&hepatoprotectivepotentialinstreptozotocininduceddiabeticratsDanishAhmed,VikasKumar,HarishKumarBajaj,ManjuSharma

14:45 C064:Clinicopathologicfeaturesofmethotrexate-inducedepidermalnecrosisShuenIuHung,TingJuiChen,WenHungChung

15:30 Plenary Lecture Hall A miRNAs as potential therapeutic targets in cardiovascular disordersStefanieDimmelerGoethe-UniversityFrankfurtamMain,GERMANY


20

Tuesday, 28th June 201609:00-12:00 Main Session Tuesday, 28th June 2016, Hall A:

How to improve translation from animals to humans(JointSectionofEPHARandEACPT)Organizerandchair:GérardA.Rongen(RadboudUniversity,TheNETHERLANDS)

09:00 Innovationincardiovascularpharmacotherapy:InnovationstuckintranslationGérardA.RongenRadboudUniversity,TheNETHERLANDS

09:30 Preclinicalmodelsincardiovascularresearch:itspredictivevalueinhumandrugdevelopment.LimitationsandopportunitiesMercèRoquéHospitalClínicdeBarcelona,SPAIN

10:00 Elevatedtalk(C013):EffectsofniacinandfattyaciddietarysupplementationonadiposetissuemetabolicandinflammatoryresponsesinamousemodelofmetabolicsyndromeSergioMontserratDeLaPazInstitutodelaGrasa,CSIC,SPAIN(Authors:SergioMontserratDeLaPaz,MariaCNaranjo,MariaCMillanLinares,SergioLopez,RocioAbia,ErikA.l.Biessen,FranciscoJ.gMuriana,BeatrizBermudez)

10:15 Elevatedtalk(C014):Montelukastattenuatesabdominalaorticaneurysminrats:roleonmatrixmetalloproteinasesÇağlarMacitİstanbulMedipolUniversity,TURKEY(Authors:GözdeTekin,GökselŞener,ÖzgeÇevik,ŞuleÇetinel,ÇağlarMacit)

10:30 Coffeebreak11:00 Improvementofpreclinicalanimalmodelsforautoimmune-mediateddisordersvia

reversetranslationoffailedtherapiesBert‘THartBiomedicalPrimateResearchCentre,TheNETHERLANDS

11:30 Elevatedtalk(C015):Nebivololmediatesp44/42MAPKphosphorylationinexperimentalcardiachypertrophymodelinducedbyneurohumoralstimulationIşılÖzakcaAnkaraUniversity,TURKEY(Authors:IsilÖzakca,MesutÇiçek,VecdiMelihAltan,ArifTanjuÖzçelikay)



21

09:00-12:00 Main Session Tuesday, 28th June 2016, Hall B: Emerging therapeutic targets in chronic pain and inflammation(OrganizedbyHungarianSocietyforExperimentalandClinicalPharmacology)Organizersandchairs:BeataSperlagh(HungarianAcademyofSciences,HUNGARY)ZsuzsannaHelyes(UniversityofPecs,HUNGARY)

09:00 Centralmechanismofbotulinumtoxinactiononpainsupersensitivity,allodyniaandmigraineZdravkoLackovićUniversityofZagreb,CROATIA

09:30 ExtracellularvesiclesandtheirtherapeuticpotentialininflammatorydiseasesAgnesKittelHungarianAcademyofSciences,HUNGARY

10:00 Analgesiceffectsofthenovelsemicarbazide-sensitiveamine-oxidaseinhibitorSzV-1287inanimalmodelsofchronicpainZsuzsannaHelyesUniversityofPecs,HUNGARY

10:30 Coffeebreak11:00 Elevatedtalk(C016):InhibitionofNLRP3inflammasomepreventslipopolysaccharide-

inducedInflammatoryhyperalgesiainmice:contributionofNF-kB,caspase-1/11,ASC,NADPHoxidase,andNOSisoformsBaharTunçtanMersinUniversity,TURKEY(Authors:BaharTunctan,AbdurrahmanDolunay,SefikaPinarSenol,MeryemTemizReşitoğlu,DemetSinemGuden,AyseNihalSari,SeyhanSahanFirat)

11:15 Elevatedtalk(C017):InvestigatingtheanalgesiceffectofFAAHinhibitorJNJ-1661010aloneandincombinationwithCOXinhibitorsNergizHacerTurgutCumhuriyetUniversity,TURKEY(Authors:NergizHacerTurgut,AhmetAltun,MerveErgul,MuhammedMucahitCicek,BulentSarac,IhsanBagcivan)

11:30 Elevatedtalk(C018):TheanalgesiceffectofFAAHinhibitorAM-1172aloneandincombinationwithiNOSinhibitorsBYKandSMAhmetAltunCumhuriyetUniversity,TURKEY(Authors:AhmetAltun,NergizHacerTurgut,MerveErgul,MuhammedMucahitCicek,BulentSarac,SahinYildirim)


SCIENTIFIC PROGRAMMETuesday, 28th June 2016

22

09:00-12:00 Main Session Tuesday, 28th June 2016, Hall C: Calcium signalling induced by sphingosine-1-phosphate and other agonists in urogenital tract(OrganizedbyTurkishPharmacologicalSociety)Organizerandchair:NezahatTuğbaDurlu-Kandilci(HacettepeUniversity,TURKEY)

09:00 TherolesofsphingosineinlysosomalcalciumsignallingandNiemann-PickdiseasetypeCDorisHöglingerUniversityofOxford,UK

09:30 Sphingosine-1-phosphateandcarbacholinducedsecondarymessengersindetrusorNezahatTuğbaDurlu-KandilciHacettepeUniversity,TURKEY

10:00 NewsightsincalciumsignallinginmyometriumÖzgürÖktemKoçUniversity,TURKEY

10:30 Coffeebreak11:00 Elevatedtalk(C020):Sphingosine-1-phosphate(S1P)inducedcontractileresponsesin

detrusorsmoothmuscleofratshavingcyclophosphamideinducedcystitisIrfanAnjumHacettepeUniversity,TURKEY(Authors:IrfanAnjum,MerveDenizalti,N.TugbaDurluKandilci,InciSahinErdemli)

11:15 Elevatedtalk(C021):FinetuningcontrolofcholinergicnerveactivitybyexcitatoryP2X2/3andinhibitoryP2Y12receptorsinmenwithprostaticbladderobstructionIsabelSilvaUniversidadedoPorto,PORTUGAL(Authors:IsabelSilva,MiguelSilvaRamos,FátimaFerreirinha,JuliePelletier,JeanSévigny,PauloCorreiaDeSá)

11:30 Elevatedtalk(C022):InvestigationofthefunctionalresponsesofmyometriumsmoothmuscleinsecondhandsmokingandchronicalcoholconsumingratsSemilSelcenGöçmezKocaeliUniversity,TURKEY(Authors:SemilSelcenGocmez,ZeynepEceKorun,TugceDemistasSahin,TijenUtkan)

11:45 Elevatedtalk(C023):EndothelialdysfunctioninthehumanumbilicalarteryduetopreeclampsiacanbepreventedbysildenafilEdibeMinareciAkdenizUniversity,TURKEY(Authors:EdibeMinareci,NurtenKayacan,GulaySadan,BoraDinç)



23

09:00-12:00 Main Session Tuesday, 28th June 2016, Hall D: Signalling pathways in vascular function and dysfunction(OrganizedbyTurkishPharmacologicalSociety)Organizersandchairs:GünayYetikAnacak(EgeUniversity,FacultyofPharmacy,DepartmentofPharmacology)B.SönmezUydeşDoğan(İstanbulUniversity,FacultyofPharmacDepartmentofPharmacology)

09:00 Hsp90:AregulatorofvascularrelaxationGünayYetikAnacakEgeUniversity,TURKEY

09:30 ControlofhumanvasculartonebyprostanoidpathwayGökçeTopalİstanbulUniversity,TURKEY

10:00 DysregulatedNO/cGMPsignallinginpriapismF.SenaSezenKaradenizTechnicalUniversity,TURKEY

10:30 Coffeebreak11:00 Vascularroleofadipocytokinesinhealthanddiseases

JohanVanDeVoordeGhentUniversity,BELGIUM

11:30 Elevatedtalk(C024):TheeffectofPVATonvasculartoneregulationofhumancoronaryvessels:RoleofH2SandPGE2GülsevÖzenİstanbulUniversity,TURKEY(Authors:GulsevOzen,IngridGomez,LarissaKotelevets,EricChastre,CatherineDeschildre,LiliaBoubaya,DanLongrois,SonmezUydesDogan,GokceTopal,JeanBaptisteMichel,XavierNorel)

11:45 Elevatedtalk(C025):Theroleofvoltage-dependentpotassiumchannelsintherelaxationofrenalarteryofdiabeticratsLjiljanaGojkovicBukaricaUniversityofBelgrade,SERBIA(Authors:LjiljanaGojkovicBukarica,JasminaMarkovicLipkovski,HelmutHeinle,SanjaCirovic,JovanaRajkovic,VladimirDjokic,RadmilaNovakovic)



24

13:30 Plenary Lecture, Hall A Purinergic signaling in adult neural progenitor cell functions: Experimental basis and possible therapeutic significancePeterIllesUniversitätLeipzig,GERMANYSponsor:HungarianSocietyforExperimentalandClinicalPharmacology

15:00-16:30 Oral Presentation Session 6, Tuesday, 28th June 2016, Hall A Neuropharmacology/PsychopharmacologyChairs: AlettaDKraneveld(UtrechtUniversity,TheNetherlands) FilippoDrago(UniversityofCatania,Italy)

15:00 C065:DietaryinterventionsthatreducemTORactivityrescueautistic-likebehavioraldeficitsinmiceJiangboWu,CarolineGmDeTheije,SofiaLopesDaSilva,SuzanneAbbering,HilmaVanDerHorst,LausBroersen,MartienJKas,JohanGarssen,AlettaDKraneveld

15:15 C066:Theeffectofearlylifesupplementationofnon-digestibleoligosaccharidesonbraindevelopmentandfunctioninhealthymiceKirstenSzklany,CindydeWaard,NienkeG.vanStaveren,TheclaA.vanWageningen,MonikaVerdouw,KeesvanLimpt,HarmWopereis,LucianneGroenink,RaishOozeer,LeonM.J.Knippels,JohanGarssen,AlettaD.Kraneveld

15:30 C067:Investigationoftheinvolvementofdopaminergicreceptorsubtypesinthegallicacid-inducedantidepressant-likeactivityNazlıTuran,ÖzgürDevrimCan,ÜmideDemirÖzkay,YusufÖztürk

15:45 C068:Dopaminergicreceptorsubtypesmediatedantidepressant-likeactivityofquercetinFeyzaAlyu,ÜmideDemirÖzkay,ÖzgürDevrimCan,YusufÖztürk

16:00 C069:Frompharmacogeneticstopersonalizedmedicine:RegulatoryperspectivesandImplicationsforLatin-AmericancountriesDiadelisDiadeRemirez

15:00-16:30 Oral Presentation Session 7, Tuesday, 28th June 2016, Hall B CardiovascularPharmacologyChairs: FatmaAkar(GaziUniversity,Turkey) PınarYamantürkÇelik(İstanbulUniversity,Turkey)

15:00 C070:ActivationofPPARβ/δimprovesendothelialdysfunctionandprotectskidneyinamousemodelofsystemiclupuserythematosusMiguelRomero,MartaToral,IñakiRoblesVera,RosarioJimenez,FranciscoO’valle,AlbaRodriguezNogales,JulioGalvez,JuanDuarte


25

15:15 C071:EffectofhighglucoseonvascularfunctionandeNOS/AktpathwayinIsolatedrataorta:ModulatoryrolesofresveratrolandjugloneFatmaAkar,MehmetBilgehanPektas,OzgeTuran,GozdeOzturk,GokhanSadi

15:30 C072:EffectsoftaurineinamodelofoxidativestressinducedbyglutathionedepletioninrabbitcarotidarteriesGonenOzsarlakSozer,GulnurSevin,GunayYetikAnacak,HakanOzgur,ZelihaKerry

15:45 C073:EffectsofpsychoactivedrugsonantihypertensivetreatmentSibelAkbilekBatmaz,IlirianaAlloqiTahirbegolli,BernardTahirbegolli,BerrinUmman,PınarYamantürkÇelik

16:00 C074:FunctionaleffectsofP2X7receptorsinhumaninternalthoracicarteriesZelihaBayram,IkbalOzenKücükcetin,SebahatOzdem,CahitNacitarhan,CengizTürkay,SadiS.Ozdem

16:15 C091:InvestigationoftheeffectsofvitaminUonceacalflorainratswithliverandrenalischemia/reperfusioninjurySatıZeynepTekin,ÖzlemÖztopuz,HakanTürkön,AslıKiraz,MuhammetKasımArık,UfukDemir,SaitElmas,MehmetAkifOvalı,UğurAltınışık

16:30 C075:Preventionofprogressivecardiacremodellingbyhistamine2receptorantagonism–anovelapproachAjayGodwinPotnuri,LingeshAllakonda,ArulVelanAppavoo,RenukaRNair

15:00-16:30 Oral Presentation Session 8, Tuesday, 28th June 2016, Hall C PharmacokineticsandDrugMetabolismChairs: AbdullahTuncayDemiryürek(UniversityofGaziantep,Turkey) SelimKortunay(PamukkaleUniversity,Denizli,Turkey)

15:00 C076:Deprivationoftheessentialnutrientcholine:theimpactondrugmetabolismCharisLiapi,DimitriosSegos,HussamAlHumadi

15:15 C077:EvidencefortheassociationbetweenTRPM7genepolymorphismsandpreeclampsiaBelginAlaşehirli,ZekiyeDoğantürk,ElifOğuz,SerdarÖztuzcu,ŞenizDemiryürek,ReyhanGündüz,MeteGürolUğur,AbdullahTuncayDemiryürek

15:30 C078:EvaluationofcytochromeP4502C9enzymeactivityinpatientwithankylosingspondylitisMustafaTuğrulGöktaş,HalilKara,ErdemKamilÖzer,İlknurAlbayrakGezer,ÜmitYaşar

15:45 C079:DeterminationofCYP2C9activityinpatientswithsystemiclupuserythematosusMustafaTuğrulGöktaş,ErdemKamilÖzer,AhmetMüderrisoğlu,SaidKalkışım,EmelC.Emlakcıoğlu,ÜmitYaşar

16:00 C080:PharmacokineticsofS-ketamineandS-norketamineafterracemicorS-ketamineIVbolusadministrationindogsduringsevofluraneanaesthesiaAndreaBarbarossa,NoemiRomagnoli,RimaBektas,AnnetteKutter,PaolaRoncada,RegulaBettschartWolfensberger


26

16:15 C081:PharmacokineticsofS-ketamineandS-norketaminefollowingracemicorS-ketamineIVbolusadministrationindogspremedicatedwithmedetomidineNoemiRomagnoli,AndreaBarbarossa,RimaBektas,AnnetteKutter,PaolaRoncada,RegulaBettschartWolfensberger

15:15-16:15 Oral Presentation Session 9, Tuesday, 28th June 2016, Hall D ReceptorsandCellSignallingChairs:MojcaKrzan(UniversityofLjubljana,Slovenia) HakanGürdal(AnkaraUniversity,Turkey)

15:00 C082:Highglucose-inducedSRCkinaseactivitycauses5-hydroxytryptaminereceptorsubtypesmediatedEGFRtransactivationinA7R5cellSahikaGuner,TamilaAkhayeva,HakanGurdal

15:15 C083:DeuterationafffectsthebindingbutnotfunctionalcharacteristicofglialhistamineH2receptorMojcaKrzan,NikaJurisevic,AnzeZorc,JanezMavri

15:30 C085:AnovelproteolyticcleavageofROCK1bycaspase-2Burçinİbişoğlu,AysunÖzdemir,YaprakDilberŞimay,MustafaArk

15:45 C086:FunctionalizedhyaluronicacidbasedbiomaterialandassessmentofitssafetyandwoundhealingactivityinacuteanddiabeticskinwoundmodelsBaibaJansone,JoannaJenina,KatrinaJukevica,MartinsBoroduskis,ZaneDzirkale,ElgaPoppela,LienePatetko,JelenaEglite,ElviraHagina,AnnaRamataStunda

16:00 C087:ThereversaleffectofondansetrononbupivacaineinducedsciaticnerveblockinratsAliOzgulSaltali,SezaApiliogullari,SengalBagciTaylan,MustafaFevziSargon,JaleBengiCelik,IbrahimOzkanOnal

16:15 C090:Antithromboticeffectofnewcyclohexilammoniumsalt2-[1-ethyl-3-methyl-7-(dioxothietanyl-3)xanthinyl-8-thio]aceticacidonexperimentalvenousthrombosisAleksandrV.Samorodov,FelixKh.Kamilov,FerkatA.Khaliullin,YuliyaV.Shabalina,AlmazR.Khalimov,DaniyarZ.Murataev

15:00-16:30 Oral Presentation Session 10, Tuesday, 28th June 2016, Hall E DrugDiscovery,DevelopmentandEvaluationChair:N.TuğbaDurluKandilci(HacettepeUniversity,Turkey)

15:00 C088:In-vivoevaluationofthepreventiveeffectoftheethanolicleafextractofHibiscusrosa-sinensis(Malvaceae)againstcalciumoxalatecrystalsinethyleneglycol-andammoniumchloride-inducedhyperoxaluriainadultmalealbinoSwissmiceRhemceePascual,MonicaDelRosario,JarrahPatacsil,MayPleños,PrescillaSanPedro,ShannenSuñga,JoseVillanueva,AlethDacanay,MayMagtoto,GregoryMartin


27

15:15 C089:DimethoxyflavoneisolatedfromthestembarkofStereospermumkunthianumpossessesantidiarrhoealactivityinrodentsFidelisPohChing,OtokitiAbrahimNosahare

15:30 C092:InhibitoryeffectofhydroalcoholicextractofgreenteaoncognitiveimpairmentandoxidativestressinducedbystreptozocininratsAminAtaee,RaminAtaee

09:00-12:00 Main Session Wednesday, 29th June 2016, Hall A: Dopamine signaling in health and disease(OrganizedbyDanishSocietyofPharmacology)Organizerandchair:ClausJuulLoland(UniversityofCopenhagen,DENMARK)

09:00 Developmentandbindingcharacterizationofhigh-affinitymodafinilanalogousaspotentialantagonizersofcocainesubjectiveeffectsClausJuulLolandUniversityofCopenhagen,DENMARK

09:30 ModulationofdopaminergicpathwaystoimproveerectilefunctionUlfSimonsenAarhusUniversity,DENMARK

10:00 Thedopaminetransporterastargetfornewpsychoactivesubstances:amechanismofactionHaraldSitteMedicalUniversityofVienna,AUSTRIA

10:30 Coffeebreak11:00 Modulatingdopamineneuronsinvisualattentionusingpharmacogenetics

DavidP.WoldbyeUniversityofCopenhagen,DENMARK

11:30 Elevatedtalk(C026):RopinirolepreventstheaddictionandwithdrawalsymptomsofmorphineinducedconditionplacedpreferenceinratsAndleebShahzadiIstanbulUniversity,TURKEY(Authors:EnesKarabulut,OrucAllahverdiyev,AndleebShahzadi,ZelihaYazici)

11:45 Elevatedtalk(C027):Antidepressant-likeeffectsofBaijinCapsuleintheolfactorybulbectomizedratJianningSunBeijingUniversityofChineseMedicine,CHINA(Authors:RongZhang,YaoyueLiang,ShifenDong,JianNi,JianningSun)


SCIENTIFIC PROGRAMMEWednesday, 29th June 2016

28

09:30-12:00 Main Session Wednesday, 29th June 2016, Hall B: Basic and translational pharmacology of hydrogen sulfide: molecular targets and targeted diseases(JointSectionofItalianSocietyofPharmacologyandHellenicSocietyofBasicandClinicalPharmacology)Organizersandchairs:GiuseppeCirino(UniversityofNaples)AndreasPapapetropoulos(UniversityofAthens)

09:30 CurrentstatusofH2SinhibitorsAndreasPapapetropoulosUniversityofAthens,GREECE

10:00 CBSinhibitionincancerCsabaSzaboUniversityofTexasMedicalBranch,USA

10:30 Coffeebreak11:00 The“two-pharmacophore”approach:improvingthesafetyofNSAIDswiththehelpofH2S

JohnL.WallaceAntibeTherapeutics,CANADA

11:30 Elevatedtalk(C028):TheinteractionofL-cysteine/hydrogensulfidepathwayandmuscarinicacetylcholinereceptors(mAChRs)inmousecorpuscavernosumFatmaTuğçeDalkırÇukurovaUniversity,TURKEY(Authors:FatmaTuğçeDalkır,FatmaAydınoğlu,NuranÖğülener)

11:45 Elevatedtalk(C029):H2Sdonorsincreasecystathionine-γlyaseexpressionSofiaIrisBibliNationalandKapodistrianUniversityofAthens,GREECE(Authors:SofiaIrisBibli,CsabaSzabo,AndreasPapapetropoulos)

12:00 Endofsymposium09:00-12:00 Main Session Wednesday, 29th June 2016, Hall C:

Trace amine associated receptors (TAARs): a promising target for pharmacotherapies?(OrganizedbyBritishPharmacologicalSociety)


29

Organizersandchairs:ClareStanford(DeptNeurosciencePhysiology&Pharmacol,UCL,UK)StefanoEspinoza(ItalianInstituteofTechnology,ITALY)

09:00 Traceaminereceptors:theirroleinpsychosisanditstreatmentStefanoEspinozaItalianInstituteofTechnology,ITALY

09:30 TAAR1ligandsasnewgenerationpharmacotherapiesforaddictiontreatmentJuanCanalesUniversityofLeicester,UK

10:00 TAAR1-mediatedmodulationofpresynapticdopaminergicneurotransmission:roleofD2dopaminereceptorsDamianaLeoItalianInstituteofTechnology,ITALY

10:30 Coffeebreak11:00 Non-classicalaminerecognitionevolvedinalargecladeofolfactorytraceamine-

associatedreceptorsQianLiHarvardMedicalSchool,USA

11:30 Elevatedtalk(C030):DiscoveryofnovelTAAR1ligandsthroughtheuseofinsilicoscreeningonahomologymodelofthetraceamineassociatedreceptor1VincentM.LamUniversityofToronto,CANADA(Authors:LamVM,RodríguezD,ZhangT,KohEJ,CarlssonJ,SalahpourA)

12:00 Endofsymposium09:00-12:00

Main Session Wednesday, 29th June 2016, Hall D: Molecular clocks and chronopharmacology(OrganizedbyTurkishPharmacologicalSociety)Organizersandchairs:FrancisLevi(WarwickUniversity)AlperOkyar(İstanbulUniversity)

09:00 DiscoveryofthesmallmoleculesthatregulatescircadianrhythmİbrahimHalilKavaklıKoçUniversity,TURKEY

09:30 ModellingthelinkbetweencircadianclockandcancerNuriÖztürkGebzeTechnicalUniversity,TURKEY

10:00 SystemschronopharmacologyofanticancerdrugsfromcellstopatientsFrancisLeviWarwickUniversity,UK


30

10:30 Coffeebreak11:00 Circadiancontrolofdrugmetabolism,detoxificationandpharmacokinetics

AlperOkyarİstanbulUniversity,TURKEY

11:30 Elevatedtalk(C031):RelevanceofeverolimusdosingtimefortoxicityandcircadianclockeffectsinmiceXiaoMeiLiINSERM,UniversitéParis-Sud,FRANCE(Authors:XiaoMeiLi,ThinhDoan,NarinOzturk,AlperOkyar,BarbelFinkenstadtRand,SylvieGiacchetti,FrancisLévi)

11:45 Elevatedtalk(C032):ThecircadiantimingsystemasatoxicitytargetoftheanticancermTORinhibitoreverolimusinmiceNarinÖztürkİstanbulUniversity,TURKEY(Authors:NarinOzturk,DilekOzturk,ZelihaPalaKara,EnginKaptan,SerapSancarBas,SuzanCinar,GunnurDeniz,XiaoMeiLi,SylvieGiachetti,FrancisLevi,AlperOkyar)

12:00 Endofsymposium09:00-12:00 Workshop Wednesday, 29th June 2016, Hall E:

ORPHEUS platform: “Best Practices for High Research Standards and PhD Students training in Responsible Research”(OrganizedbyORPHEUS:ORganisationofPhDEducationinBiomedicineandHealthSciencesintheEUropeanSystem)Organizerandchair:ZdravkoLacković(UniversityofZagreb,CROATIA)

09:00 BestpracticesforhighresearchstandardsandPhDstudentstraininginresponsibleresearchZdravkoLackovićUniversityofZagreb,CROATIA

09:30 InstitutionalproceduresasatooltopromoteresponsibleresearchenvironmentHakanSedatOrerKoçUniversity,TURKEY

10:00 ORPHEUStoolsforassistinginstitutionsinimplementingbestpracticesforresponsibleresearchtrainingMichaelJohnMulvanyAarhusUniversity,DENMARK

10:30 Coffeebreak11:00 ImpactofORPHEUSonPhDtraining:TheexperienceofaTurkishuniversity

GülGünerAkdoğanİzmirUniversityofEconomics,TURKEY

11:30 Discussion12:00 Endofsymposium


31

13:30 Plenary Lecture, Hall A Poly(ADP-ribose) polymerase: Pathomechanisms and therapeutic opportunitiesCsabaSzaboTheUniversityofTexasMedicalBranch,USA

15:00-16:30 Oral Presentation Session 11, Wednesday, 29th June 2016, Hall A PainandInflammation;GasotransmittersChairs: NuranOgulener(ÇukurovaUniversity,Turkey)

15:00 C093:OndansetronshortensthedurationofthethermalantinociceptiveeffectsofbupivacaineintheratpawAydinMermer,AliÖzgülSaltali,IpekDuman,BülentHanedan,SengalTaylanBagci,YasinTire,SezaApiliogullari

15:15 C094:TheeffectsofvascularcytocromeP450Inhibitorsonmesentericbloodflow,vascularhyporeactivity,organdamageandsurvivalinanexperimentalsepticshockmodelSeldaErtaçSerdar,KemalKösemehmetoğlu,AlperBektaşİskit

15:30 C095:ImmunomodulatoryeffectofminocyclineinmousecolitisJoseGarridoMesa,AlbaRodriguezNogales,FrancescaAlgieri,TeresaVezza,NatividadGarridoMesa,DeseadaCamuesco,MariaPilarUtrilla,MariaElenaRodriguezCabezas,FedericoGarcia,NataliaChueca,JulioGalvez

15:45 C096:BlockingofurotensinreceptorsasnewtargetfortreatmentofcarrageenaninducedinflammationinratsElifCadirci,ZekaiHalici,MuhammedYayla,ErdemToktay,YasinBayir,EmreKarakus,AtillaTopcu,BasakBuyuk,AbdulmecitAlbayrak

16:00 C097:Dopenilehemodynamicschangeinthepresenceofhydrogensulfide(H2S)donorinthemetabolicsyndrome-inducederectiledysfunction?EzgiDayar,ErkanKara,GunayYetikAnacak,NilHocaoglu,OzanBozkurt,SedefGidener,NergisDurmus

16:15 C098:Theeffectsofcyclooxygenase,nitricoxide,phosphodiesteraseIVandRho-kinaseinhibitorsonhydrogensulfide-inducedrelaxantresponseinmousecorpuscavernosumFatmaAydinoglu,NuranOgulener

15:00-16:30 Oral Presentation Session 12, Wednesday, 29th June 2016, Hall B CancerChemotherapy;RespiratoryPharmacology;GenitourinaryandReproductivePharmacologyChairs: ZelihaYazıcı(İstanbulUniversity,Turkey) AhmetAltun(CumhuriyetUniversity,Turkey)


32

15:00 C099:Protectiveeffectofhypericumtriquetrifoliumturra.oncyclophosphamide–inducedmyelotoxicityandhemotoxicityinratSongülÇetik,AdnanAyhancı,CumaliKeskin

15:15 C100:Thecytotoxiceffectsofestrogentargetednano-silvermoleculesonplatinumresistantovariancancercellsline(OVCAR-3)AhmetAltun,NevcihanGursoy,MarijaSevcenko,AhmetTuranDemir

15:30 C101:ExpressionalalterationsofCYP1A2,CYP2J3andCYP3A1inratliverandheartupondoxorubicinandciprofloxacintreatmentAndleebShahzadi,EsraGuzel,OmerFarukKaratas,IkbalSonmez,MustafaOzen,ZelihaYazici

15:45 C102:PharmacokineticsofchronomodulatedcapecitabineasapartoffirstlineXELOXchemotherapyinmetastaticcolorectalcancerpatientsZelihaPalaKara,KezbanNurPilanci,SezerSaglam,AlperOkyar

16:00 C103:ProtectiveeffectofhypericumperforatumextractoncigarettesmokeinducedlunginflammationHalilMahirkaplan,ErginŞingirik,FigenDoran

16:15 C104:Chronicunpredictablemildstressimpairsneurogenicandendothelium-dependentrelaxationofrabbitcorpuscavernosumsmoothmuscle:improvementwithchronicadministrationofresveratrolSemilSelcenGocmez,TugceDemirtasSahin,TijenUtkan

15:00-16:30 Oral Presentation Session 13, Wednesday, 29th June 2016, Hall C GastrointestinalPharmacology;RationalDrugUseChairs: AtilaKaraalp(MarmaraUniversity,Turkey) ElifÇadırcı(AtatürkUniversity,Turkey)

15:00 C105:Protonpumpinhibitoruseforatwelve-monthperiodisnotassociatedwithchangesinserummagnesiumlevels:aprospectiveopenlabelcomparativestudyEltonBahtiri,HilmiIslami,RexhepHoxha,HasimeQorrajBytyqi,ShaipKrasniqi,KujtimThaçi,ValonKrasniqi,LiridonHaziri,MalboraMusa

15:15 C106:TheroleofTLR4ingut-braincrosstalkinamurinemodelforParkinson’sdiseasePaulaPerezPardo,HemrajBDodiya,JohanGarssen,AliKeshavarzian,AlettaDKraneveld

15:30 C107:Theeffectofurantide,anurotensinereceptorantagonist,onthehealingofindomethacin-inducedgastriculcerinratsZekaiHalici,ElifCadirci,BusraDiyarbakir,MuhammedYayla,DamlaCetin,ZerrinKutlu,EminSengul

15:45 C108:PotentiallyinappropriatedruguseinelderlypatientsadmittedtotheintensivecareunitofauniversityhospitalMedineGulcebi,SongulOzkula,NesrinDuman,GozdeAyhan,ZehraTurgan,RezzanGulhan,AtilaKaraalp,FilizOnat,ZaferGoren


33

16:00 C109:Self-MedicationpracticeamongpreclinicalmedicalstudentsandlawstudentsofMarmaraUniversityAkifKöse,AsibeTürkkan,MelikeÜlküAydın,ÖzlemAlhan,YasinYıldız,MikailÖzdemir,SeyhanHıdıroğlu,RezzanGülhanAker

16:15 C110:AssessmentofantibioticprescribingperformanceofdentistsinTurkeyMehtapAydın,CenkerZKoyuncuoglu,IpekKirmizi,EsmaKadi,AliAlkan,AhmetAkici

16:30 C119:InvestigationoftheeffectsofoleuropeinrichdietonratentericbacterialfloraAslıKiraz,TuncerŞimşek,SatıZeynepTekin,SaitElmas,MuratTekin,HasanŞahin,HaticeBetülAltınışık,ÇiğdemUysalPala

15:00-16:30 Oral Presentation Session 14, Wednesday, 29th June 2016, Hall D DrugDiscovery,DevelopmentandEvaluation;DrugsforInfectiousDiseasesChairs: HakanParlakpınar(İnonüUniversity,Turkey) AtillaAkdemir(BezmialemVakifUniversity,Turkey)

15:00 C111:EffectsofperineuraladministrationofphenytoinincombinationwithlevobupivacaineinaratsciaticnevreblockAhmetSelimOzkan,SedatAkbas,MehmetAkifDurak,MehmetAliErdogan,HakanParlakpınar,NigarVardı,OnurhalOzhan,AliOzer

15:15 C112:1H-indole-2,3-dione3-[N-(4-sulfamoylphenyl)thiosemicarbazone]derivativesasputativeanticancerandantifungalagentsAtillaAkdemir,NilgünKaralı,ClaudiuT.Supuran

15:30 C113:InvitroinvestigationoftherapeuticeffectsofMyrtuscommunisL.inCancerCellLinesAyşeGürel,HacerEsraGürsesCila,ÖmerFarukHatipoğlu,EsraGündüz

15:45 C114:ProtectiveeffectsofcoenzymeQ10onsurvival,vascularandtissueinjuryinsepsisErdemKamilOzer,MustafaTugrulGoktas,IbrahimKilinc

16:00 C115:Hasinfliximabprotectiveeffectsonsurvival,vascularandtissueinjuryinsepsis?ErdemKamilOzer,MustafaTugrulGoktas,IbrahimKilinc

16:15 C116:Protectiveeffectsofcelecoxibeonsurvival,vascularandtissueinjuryinsepsisErdemKamilOzer,MustafaTugrulGoktas,AysunToker

16:30 C118:Adversedrugreactionstoanti-TBDrugs:PharmacogenomicsPerspectiveforidentificationofhostgeneticmarkersKamalKishor,RoshanKumarSahu

09:00-12:00 Main Session Thursday, 30th June 2016, Hall A: Targeting inflammation in disease(OrganizedbySpanishSocietyofPharmacology)


34

Organizersandchairs:Maria-JesusSanz(UniversityofValencia)JuanTamargo(ComplutenseUniversityofMadrid)

09:00 InflammationplaysaroleinthepathophysiologyandrepresentsatherapeutictargetinatrialfibrillationJuanTamargoComplutenseUniversityofMadrid,SPAIN

09:30 ThemicrobiotaasapharmacologicaltargetforthetreatmentofintestinalinflammatorydiseasesJulioGálvezUniversityofGranada,SPAIN

10:00 Elevatedtalk(C033):CorrelationofIL-1betalevelsandacutephaseproteinsinpatients’serafromaphase2familialmediterraneanfevertrialwithcanakinumabSerhanSevgiNovartisPharmaMedicalDepartment,TURKEY(Authors:SerhanSevgi,HuriOzdogan,OzgurKasapcopur,BurakErer,SerdalUgurlu,SonerTurgay,AhmetGul)

10:15 Elevatedtalk(C034):Protectiveeffectsofpentoxifyllineanditspotentiationwithlowdosenitricoxide(NO)modulatorsincompleteFreund’sadjuvant-inducedrheumatoidarthritisinratsRishiPalKingGeorge’sMedicalUniversity,INDIA(Authors:RishiPal,PrafullaChandraTiwari,RajendraNath,KamleshKumarPant)

10:30 Coffeebreak11:00 Istherearoomforantiinflammatorydrugsinneuropsychiatry?

Juan-CarlosLezaComplutenseUniversityofMadrid,SPAIN

11:30 Therapeuticpotentialofbloodglutamategrabbinginstroke:aproofofconceptMaria-IsabelLozaUniversityofSantiagodeCompostela,SPAIN

12:00 Endofsymposium09:00-10:30 Main Session Thursday, 30th June 2016, Hall B:

European Registered Pharmacologist Project(OrganizedbyEPHARandEACPT)Organizerandchair:ThomasGriesbacher(MedizinischeUniversitätGraz,AUSTRIA)

SCIENTIFIC PROGRAMMEThursday, 30th June 2016

35


Speakersfromtherelevantsocietiestobeannounced10:30 Endofsymposium10:30 Coffeebreak11:00 EJP Educational Seminar, Hall B

Howtowritegreatpapers:Fromtitletoreferences,fromsubmissiontopublicationJaapVanHartenElsevierBV,TheNETHERLANDS

09:00-12:00 Main Session Thursday, 30th June 2016, Hall C: New insights in neuropsychiatric disorders: models & molecules with therapeutic potential(OrganizedbyTurkishPharmacologicalSociety)Organizersandchairs:EceGenç(YeditepeUniversity)FeyzaAricioğlu(MarmaraUniversity)

09:00 Currentandfuturepharmacologyofpost-traumaticstressdisorderZaferGörenMarmaraUniversity,TURKEY

09:30 Convulsionstriggeredbyfoodintakeinantimuscarinic-treatedfastedanimals:amodelforeatingseizures?NurhanEnginarİstanbulUniversity,TURKEY

10:00 NoveltargetsfocusingonneuroinflammationandneurogenesisinschizophreniaFeyzaAricioğluMarmaraUniversity,TURKEY

10:30 Coffeebreak11:00 CanvalproicacidhaveatherapeuticpotentialinParkinson’sdisease?

EceGençYeditepeUniversity,TURKEY

11:30 Elevatedtalk(C035):Neuroprotectiveeffectsofepicatechinagainsthomocyctein-inducedoxidativestressinhippocampalareainratRaminAtaeeMazandaranUniversityofMedicalSciences,IRAN(Authors:RaminAtaee,YaghubShayesteh,AminAtaie,EsmaeilAkbari,FatemehShaki)

36

11:45 Elevatedtalk(C036):Theeffectofthehyperpolarization-activatedcyclicnucleotide-gated(HCN)channelblockerZD72688onspike-and-wavedischargesinanimalmodelsofabsenceepilepsyNihanÇarçakYilmazİstanbulUniversity,TURKEY(Authors:NihanÇarçakYılmaz,FrancoisDavid,FilizOnat,VincenzoCrunelli)

12:00 Endofsymposium09:00-10:30 Main Session Thursday, 30th June 2016, Hall D:

Biased signaling - far beyond arrestin(OrganizedbyDutchPharmacologicalSociety)Organizerandchair:MartinaSchmidt(UniversityofGroningen,TheNETHERLANDS)*This section will be performed via Skype connection

09:00 PKAandEpacasbiasedsignalingparadigmsincAMPMartinaSchmidtUniversityofGroningen,TheNETHERLANDS

09:30 DifferentialGproteinactivationbyasingleGPCRasasignalingbiasMartinLohseUniversityofWürzburg,GERMANY

10:00 Elusiveequilibrium:TheinfluenceofkineticsonobservedsignalingbiasStevenCarltonTheUniversityofNottingham,UK

10:30 Endofsymposium11:00-12:00 Local workshop Thursday, 30th June 2016, Hall E:

Rational Drug Use12:00 Endofcongress

Monday, 27th June 201614:00-15:00 MeetingoftheEPHARECExecutive MeetingroomTuesday, 28th June 201612:30-13:30 EUCPTCommitteeMeeting Meetingroom


37

17:00-18:30 EPHARCouncilMeeting HallCWednesday, 29th June 201615:00-16:00 MeetingofthenewEPHARECExecutive Meetingroom

PARALEL MEETINGS

38

For more information about attending or presenting please contact [email protected] or visit www.bps.ac.uk/pharmacology2016.

PHARMACOLOGY 201613−15 DecemberThe Queen Elizabeth II Conference Centre, London

Register & submit your research

39

For more information about attending or presenting please contact [email protected] or visit www.bps.ac.uk/pharmacology2016.

PHARMACOLOGY 201613−15 DecemberThe Queen Elizabeth II Conference Centre, London

Register & submit your research

Cardiovascular & Respiratory Pharmacology

Drug Discovery, Development & Evaluation and Toxicology

The British Pharmacological Society is delighted to announce initial details for our annual meeting, Pharmacology 2016. The latest research from across the whole spectrum of pharmacology will be the focus for plenary lectures, oral communications and poster sessions. There will also be invaluable opportunities for participants to network with pharmacologists from the UK, Europe and overseas.

Symposia

Molecular & Cellular Pharmacology

Non-traditional/orphan GPCRS as novel therapeutic targetsBiochemical strategies in drug discovery and targetingAnti-tumour pharmacology and traditional Chinese medicine

From bench to bedside: Targeting the pathophysiological responses of ischemia-reperfusion injuriesBSCR embedded symposium: Targeting cardiovascular GPCRs using biased agonism Nanomedicine in pharmacology

The long reach of the bowel: Translating microbiome science into therapeutics for systemic human diseasesStudy, development and rationale use of immunopharmacological agentsImmuno-Oncology: From bench to bedsideTranslation to therapeutics: Resolution of inflammation

Integrative Systems Pharmacology

Uses and challenges for human pharmacology studies to understand CNS diseasesFatty acid amides (aka lipoamines) beyond cannabinoidsRecent developments in research of melatonin and its potential therapeutics application

Neuropharmacology

Organ-on-a-Chip technology - the future of physiological profiling?Clinical application of systems pharmacology modelsClinical pharmacology, pharmacokinetics and pharmacogenetics in pregnancy (C4P)

Dates for your diary

Registration opens: 24 June

Abstract submission deadline: 9 September

Bursary application deadline: 9 September

Early bird registration deadline: 9 September

40

Poster Sessions

41

Poster SessionsPoster Sessions

42

Poster Session Day 1, Monday, 27th June 2016, Poster Hall 15:00-16:30

Receptors and Cell SignallingP001 EffectofcronicalΔ9-tetrahidrocannabinoltreatmentonrho/rho-kinasesignalization

pathwayinbrainHalilMahirKaplan,ErginŞingirik

P002 Characterizationofsimultaneous5-HTandglutamatereleaseinresponsetooptogeneticstimulationofmedianrapheafferentsFlóraGölöncsér,MáriaBaranyi,DiánaBalázsfi,DóraZelena,KornélDemeter,JózsefHaller,BeátaSperlágh

P003 MechanicalforcesactivatehistamineH1receptorsSerapErdogmus,UrsulaStorch,MichaelaWinter,CarstenHoffmann,ThomasGudermann,MichaelMederosYSchnitzler

P004 Effectofcigarettesmokingonrho/rho-kinasesignalizationpathwayinlungsHalilMahirkaplan,ErginŞingirik,ArashAlizadehYegani,ErcanKarabulut

P005 TheeffectsofselectiveMC3agonistPG990andPG992onTNF-alphainducedchondrocytecelldeathandpro-inflammatorycytokinereleaseVediaCCan,IanCLocke,PaoloGrieco,StephenJGetting

P006 PterygialtissueRho/Rho-kinasegeneexpressionsAbdullahTuncayDemiryurek,SeydiOkumus,SerdarOztuzcu,YusufTuylu,UmitAksoy,EcirAliCakmak,SenizDemiryurek

P007 Epac1linksprostaglandinE2toβ-catenintranscriptionalactivityduringepithelial-to-mesenchymaltransitioninA549cellsSeppR.Jansen,WimDeJager,StephenJ.Yarwood,FrankLezoualc’h,ReinoudGosens,MartinaSchmidt

Ion ChannelsP008 EffectsofCapsaicinonhumanalpha7-nicotinicacetylcholinereceptors

LukeHowarth,EslamElNebrisi,SyedNurulain,SusanKeunHangYang,FrankHowarth,MuratOz

P009 ThedecreaseinαENaCsurfaceabundanceinculturedalveolarepithelialcellsinhypoxiadependsonHIF-2αEmelBaloglu,KalpanaVelineni,HeimoMairbäurl

P010 BioinformaticalinvestigationsofAndroctonscrassicaudascorpiontoxins:PresenceofGG4domainsSüleymanAydın,AyçaÇakmak

POSTER SESSIONS

43

Cardiovascular PharmacologyP011 TheroleofIκB-α/NF-κBpathwayactivationinhypotensionandinflammationreversedby

BAY61-3606,aselectiveSykInhibitor,inratmodelsofsepticandnon-septicshockSeyhanSahanFirat,MeryemTemizResitoglu,CuneytKemalBuharalioglu,DemetSinemGuden,SefikaPinarSenol,AyseNihalSari,MeltemKacan,DemetUnsal,BelmaKorkmaz,BaharTunctan

P012 Effectsoffreshcoconutmilkconsumptionfor6weeksonvascularfunctionsinmiddle-agedmaleratsChaweewanJansakul,SomruedeeYorsin,KanyanattKanokwirun

P013 ProtectivepropertiesofgrapepolyphenolsconcentrateonthemodelofhypertensivesyndromeinratsShynggysSergazy,ShulgauZarina,GulyayevAlexander,KhassenbekovaZhanagul,KabdulinaAnel,NurgozhinTalgat

P014 AMG9810inhibitsTRPV1channelmediatedvascularresponsesDorsaDivsalar,TamásKark,ÁgnesCzikora,GáborFülöp,TamásCsípö,AnettFényi,AndreaSzalai,AttilaTóth,RobertPórszász

P015 ImpactofdiabetesandobesityincontrolofbloodpressureinpatientsunderpharmacologicalantihypertensivetreatmentAnaCristinaCabral,MargaridaCastelBranco,MargaridaCaramona,FernandoFernandezLlimos,IsabelVitóriaFigueiredo

P016 ProtectiveeffectsofellagicacidoncardiovasculardamagecausedbyhypertensioninratsJulianaBahiaReisJordão,HellenKarinePaesPorto,AlineCarvalhoBatista,MatheusLavorentiRocha

P017 VasorelaxingeffectofresveratrolonbovineretinalarteriesLauraVandenDaele,CharlotteBoydens,BartPauwels,JohanVandeVoorde

P018 Protectiveeffectofresveratrolandquercetinoninvitro-induceddiabeticmousecorpuscavernosumCharlotteBoydens,BartPauwels,LauraVandenDaele,JohanVanDeVoorde

P019 Ketaminetreatmentreversesage-relatedvasculardysfunctioninthoracicaortaSemilSelcenGocmez,MustafaRauanSergazykyzy,ZhaznayevaZhanatKadyirbekovna,CuneytOzer,TugceDemirtasSahin,TijenUtkan

P020 Protectiveeffectsofnecrostatin-1ondoxorubicininducedcardiotoxicityZeynepErdoğmuşÖzgen,MeralErdinç,HasanAkkoç,IlkerKelle,MeryemŞeydaKaya,YusufNergiz,LeventErdinç

P021 ResveratroltreatmentreversedvasculardysfunctioninducedbychronicfluorosisinratsMehmetBulduk,GokhanOto,HulyaOzdemir,EmineDemirelYilmaz

P022 Roleofthenitricoxideonrosuvastatin-inducedrelaxationofthecalfcardiacveinduringcoolingKısmetEsraNurullahoğluAtalık,MustafaGüreşir

POSTER SESSIONS

44

P023 Relationshipwithurotensin-iipeptideandcyclosporine-aduetoendothelialdysfunctionandnephrotoxicityinratsMuratOlukman,DenizÇoşkunsever,SelviNalbant,SelimŞentürk,YiğitUyanıkgil,TürkerÇavuşoğlu,CenkCan,SibelGöksel,SonerDuman,EserSözmen,FatmaGülÇelenk

P024 Theeffectsofmelatoninonprotectionofpostconditioninginmyocardialischemiareperfusioninducedinfarctsize:Roleofmitochondrialuncouplingprotein3GülnurAslan,EnginSahna

P025 EffectsofendoplasmicreticulumstressonhypertensioninducedendothelialdysfunctioninratSevtapHan,NurBanuBal,SuzanEmelUsanmaz,OrhanUludağ,EmineDemirelYılmaz

P026 EffectsofLXRagonistGW3965onvascularreactivityinDOCA-saltinducedhypertensioninratSevtapHan,NurBanuBal,SuzanEmelUsanmaz,OrhanUludağ,EmineDemirelYılmaz

P027 Cilostazol-inducedrelaxationofcalfcardiacveinandcoronaryarteryduringcoolingKısmetEsraNurullahoğluAtalık,Z.ulyaNurullahoğlu,MehmetKılıc,AlpayArıbas

P028 EffectofperoxynitriteontheanticontractileactivityofperivascularadiposetissueAzizahUgusman,AlexandraRiddell,SimonKennedy

P029 ThetranscriptionfactorETS-2apossiblemarkerofearlyinstabilityinCABGpatientsTeresaTejerina,UrsulaMedina,ManuelCarnero,MartaRamajo,MonicaGarciaBouza,FernandoReguillo

P030 Studyofsitagliptin(inhibitorofdipeptidylpeptidase4)ontheproliferationandapoptosisofvascularsmoothmusclecellsofdiabeticandnon-diabeticpatientsJoseAntonioGonzalesCorrea,TeresaTejerina,MartaRamajo,MauricioGarciaAlonso,FernandoReguillo,SofiaDeLaSerna,UrsulaMedina

P031 TheinvitroeffectsofbotilinumtoxinAandpapaverineonradialarterygraftsÖmerTanyeli,IpekDuman,YükselDereli,HaticeToy,AyseSaideSahin

P032 Theeffectof5-lipoxygenaseinhibitionanditsinteractionwithcyclooxygenasepathwayinaratmodelofmyocardialinfarctionLeylaAbueid,AlevCumbul,AylizVelioğluÖğünç,FerihaErcan,ÜnalUslu,InciAlican

P033 ExpressionsandfunctionsofphosphodiesteraseenzymesaredifferentindifferentregionoftheratheartMehmetKursatDerici,GökhanSadi,BaşarCenik,TülinGüray,EmineDemirelYılmaz

P034 TheroleofliverXreceptorsoncardiacdysfunctioninducedbyhypertensionNurBanuBal,SevtapHan,SuzanEmelUsanmaz,OrhanUludağ,EmineDemirelYılmaz

P035 EffectofendoplasmicreticulumstressinhibitiononcardiacremodellinginducedbyhypertensionNurBanuBal,SevtapHan,SabaKiremitci,GökhanSadi,OrhanUludağ,EmineDemirelYılmaz

P036 TheeffectofflecainideandranolazineoncalciumtransientsinratcardiomyocytesSumirChawla,AnitaAlvarezLaviada,KennethMacleod

POSTER SESSIONS

45

P037 TheroleofareductionincalciumsensitivityinH2SinducedrelaxationinbovineretinalarterySelçukTakır,AyçaToprak,BirselSönmezUydeşDoğan

P038 Levosimendanconfersprotectionagainstdoxorubicininducedacutecardiotoxicitythroughinductionofanti-oxidantandanti-apoptoticmechanismsPanagiotisEfentakis,AimiliaVarela,FrageskaSigala,NikolaosKostomitsopoulos,RoxaneTenta,KathrineGioti,JohnParissis,DimitrisFarmakis,AndreasPapapetropoulos,ThomasSuter,DenisCokkinos,IoannaAndreadou

P039 Anti-atheroscleroticandcardioprotectivepropertiesofCrocussativusL.aqueousextractinApoE-/-deficientmiceEiriniChristodoulou,PanagiotisEfentakis,ZachariasIoannisKakazanis,AthanasiaChatzianastasiou,MariannaStasinopoulou,NikolaosKostomitsopoulos,NikolaosKadolglou,IonnaAndreadou,GeorgiaValsami

P040 TimololimprovesvasculardysfunctionviainhibitionofoxidativestressinDOCA-salthypertensiveratsMesutCicek,IsilOzakca,SalihErpulatOzis,ArzuOnayBesikci,ArifTanjuOzcelikay

P041 PannexinchannelsdonotinfluenceendothelialfunctioninporcinecoronaryarteriesAlaaHamedHabib,WilliamRDunn,VeraRalevic

P042 Cyclophilin-D-independenteffectsofH2SdonorsincardioprotectionAthanasiaChatzianastasiou,SofiaIrisBibli,MatthewWhiteman,IoannaAndreadou,CsabaSzabo,AndreasDaiber,AndreasPapapetropoulos

P043 InvestigationoftheeffectofanacardicacidonICAM-1,VCAM-1andNF-κBinhumansaphenousveingraftendothelialcultureinducedwithTNF-αBurakOnal,AhmetGökhanAkkan,DuyguGezenAk,BülentDemir,SibelÖzyazgan

P044 Theeffectsofpitavastatinonnuclearfactor-kappaB(NF-κB)andadhesionmoleculesinhumansaphenousveingraftendothelialcultureBülentDemir,BurakÖnal,ErdinçDursun,SibelÖzyazgan,AhmetGökhanAkkan

P045 RoleofMMP-2onvascularreactivitychangesinearlyatherosclerosisAslıArun,MehmetArun,DuyguSahin,GulnurSevin,GunayYetikAnacak

P046 TaurinerelaxeshumanradialarteryinvitroMelikSeyrek,ErkanKaya,KemalGokhanUlusoy,KubilayKarabacak,OguzhanYildiz,SuatDoganci,IbrahimDuvan,VedatYildirim,UfukDemirkilic

P047 Modulationofvasculartonebyomega-3polyunsaturatedfattyacidsinhumansaphenousveinArmondDaci,ImranUyar,GulsevOzen,OnderTeskin,BirselSönmezUydeşDoğan,GökceTopal

P048 TheassessmentoftherelaxanteffectofS-nitrosoglutathioneonisolatedhumansaphenousveinNurdanDagtekin,ErkanCivelek,DenizKaleliDurman,OnderTeskin,TanerIyigun,BirselSonmezUydesDogan

POSTER SESSIONS

46

P049 TheeffectofsirolimusandeverolimusonhumansaphenousveinErkanCivelek,DenizKaleliDurman,İlkayAlpYıldırım,ÖnderTeskin,BirselSönmezUydeşDoğan

P050 Trimetazidinepreventsleftventricularremodelinginratswithchronicalcohol-inducedcardiomyopathyLarisaKolik,JosephTsorin,AnnaNadorova,ValeryStolyaruk,MarinaVititnova,EkaterinaIonova,AlexandraSorokina,AndreyDurnev,SergeyKryzhanovsky

P051 VasorelaxanteffectofarctigenininHumanSaphenousVeinArmondDaci,ShaipKrasniqi,RaifCavolli,BurimNeziri,GiangiacomoBeretta

Vascular EndotheliumP052 IncreasedNox5expressionandRhoA/p38MAPK/NFκBactivationareinvolvedin

cigarettesmoke-inducedfunctionalarterialCXCL16expressionAidaCollado,PatriceMarques,ElenaDomingo,CristinaRius,PaulaEscudero,CruzGonzalez,EmilioServera,LauraPiqueras,MariaJesusSanz

P053 ProtectiveeffectsofPPARβ/δactivationonendothelialdysfunctioninducedbyplasmafromsystemiclupuserythematosuspatientsinhumanendothelialcellsMartaToral,RosarioJimenez,MiguelRomero,IñakiRoblesVera,ManuelSanchez,JoseMarioSabio,JuanDuarte

P054 EffectofadipokinesvisfatinandIL(interleukin)-1βinthevasculardamageinmicemesentericmicrovesselsMariellaRamosGonzalez,SusanaVallejo,AlvaroSanHipólitoLuengo,ElenaCercas,ConcepciónPeiró,CarlosSánchezFerrer

GasotransmittersP055 TherelaxanteffectsofslowreleasinghydrogensulfidedonorsGYY4137andAP66on

humansaphenousveinsandtheroleofcaveolaeSelinYamakoğlu,FatoşIlkayAlpYıldırım,GünayYetikAnacak,ÖnderTeskin,MatthewWhiteman,BirselSönmezUydeşDoğan

P056 Mechanismofrestorationofcarbachol-inducedcontractionsbyH2SindetrusorsmoothmuscleinacutecystitisMerveDenizaltı,AndreasPapapetropoulos,NezahatTuğbaDurluKandilci

Respiratory PharmacologyP057 Hydroxysaffloryellowaattenuatesbleomycin-inducedpulmonaryfibrosisinmice

MingJin,YanWu,LinWang,BaoxiaZang,LiTanP058 Protectiveeffectofhydroxysaffloryellowaoninflammatoryinjuryinchronicobstructive

pulmonarydiseaseratsMingJin,ChangjiangXue,YuWang,FangDong,YuanyuanPeng,YadanZhang,BaoxiaZang,LiTan

P059 Evaluationofthemechanismoftrachealhyperreactivityto5-hydroxytriptamineinlipopolysaccharide-inducedairwayinflammationYesimKaya,YaseminKaraman,TurgutEmrahBozkurt,InciSahinErdemli

POSTER SESSIONS

47

Endocrine PharmacologyP060 InvestigationofPTENandNOSgeneexpressionsinHashimoto’sthyroiditis

SuzanTabur,AbdullahTuncayDemiryurek,SerdarOztuzcu,ElifOguz,MesutOzkaya,SenizDemiryurek

P061 HighfructoseconsumptioncausespancreaticinflammationinratsMehmetBilgehanPektaş,TulayKoca,GozdeOzturk,GokhanSadi,FatmaAkar

P062 EvaluationofefficiencyofFrenchmaritimepinebark(Pinusmaritima)extractinhigh-fatdietandstreptozotocin-induceddiabetesinratsBedirhanAy,ErcümentÖlmez,KamilVural,TuğbaÇavuşoğlu,AhmetVar,IşılAydemir

P063 EffectsofinsulinonserumuridinelevelsinratsMesutTürkyılmaz,MehmetCansev

P064 Renin-angiotensinsysteminpathophysiologyandpharmacotherapyofosteoporosisandsarcopeniaGenkaTsvetanovaKrasteva,EmiliaTsvetanovaLakova,JoanaRumenovaNikolova,NinaEmilovaIvanova,MiroslavLyubenovDobrev,IliyaIvovDuhlenski,AygulyaMayrovaAkisheva,SabieIbrahimKorenarska

P065 Protectiveeffectofdexpanthenolagainststreptozotocin-inducedlunginjuryinratsHakanParlakpinar,HilalErmis,AlaaddinPolat,MustafaSagir

Obesity and Metabolic DiseasesP066 Alterationsinsmallmoleculemetabolitesofcardiacmuscleinexperimentaltype2

diabeticcardiomyopathyratmodelShifenDong,RongZhang,YaoyueLiang,YikunSun,JiachenShi,ShuofengZhang,JianningSun

P067 Characterizationofstreptozotocin(STZ)-induceddiabeticrats,atype1diabetesmodelwithassociatedco-morbidityClarisseDuval,PhilippeGuillaume,VincentCastagné,CamilleLeCudennec

P068 Effectsofchronicetanercept,aTNF-αinhibitor,onvascularreactivityincafeteriadiet-fedratsTugceDemirtasSahin,SemilSelcenGocmez,TijenUtkan

P069 Theeffectof“Boldine”onmetabolicsyndromeinducederectiledysfunctionErkanKara,ErkanKahraman,EzgiDayar,GunayYetikAnacak,OmerDemir,NeseAtabey,SedefGidener,NergisDurmus

P070 HypocholesterolaemiceffectsofprobioticsMajaDjanic,NebojsaPavlovic,BojanStanimirov,KarmenStankov,SvetlanaGolocorbinKon,MomirMikov

P071 TargetingadipocytedifferentiationwithHydroAlcoholicExtractofMyristicafragransseedsforthetreatmentofobesityLingeshAllakonda,SateeshKumarNanjappan,GangaModiNaidu

POSTER SESSIONS

48

P072 FractionationofwheatgermbyhighpressureextractionmethodsandevaluationofitsantioxidantpropertiesinextractsanddryplantmaterialHusseenManafikhi,RimantasVenskutonis,IlariaPeluso,RaffaellaReggi,KhaoulaAdouni,SarraBensehaila,ChristianZanza,YaroslavaLonghitano,MauraPalmery

Gastrointestinal PharmacologyP073 Intestinalanti-inflammatoryeffectsofaTheobromagrandiflorumschum.(cupuaçu)

enricheddietinthetrinitrobenzenesulfonicacidmodelofratcolitisAlexandreDaSilveiraChagas,LuizDominguesDeAlmeidaJúnior,TainanFreitasSalmeronCurimbaba,AnaElisaValenciseQuaglio,CelsoAcácioRodriguesDeAlmeidaCosta,AndersonManuelHerculanoOliveiraDaSilva,LuizClaudioDiStasi

P074 Intestinalanti-inflammatoryeffectofoliveleafextractintheDSSmodelofmousecolitisTeresaVezza,FrancescaAlgieri,AlbaRodriguez,JoseGarrido,PilarUtrilla,NassimaTalhaoui,AnaMariaGómezCaravaca,AntonioSegura,MariaElenaRodriguez,JulioGalvez

P075 ProtectiveeffectoflazariodU-74389GonexperimentalcolitisinWistarratsGalyaTzvetanovaStavreva,PlamenKrasimirovKrastev,TatyanaMarinovaBetova,AlexaderBozhidarovBlazhev,VioletaYordanovaDancheva

Genitourinary and Reproductive PharmacologyP076 HGF-cMETpathwayhasaroleintesticulardamageindiabetesinducedby

streptozotocineMukaddesGumustekin,M.AylinArici,SerapCilakerMicili,MeralKaraman,EnsariGuneli,IsılTekmen

P077 Ambroxolimprovescyclophosphamide-inducedoxydativedamageandcontractilityinmiceurinarybladderElifNurGazioğlu,SeçkinEngin,BurakBarut,MahmoudAbudayyak,MineKadıoğluDuman,ArzuÖzel

P078 EffectoffructoserichdietonratdetrusorsmoothmusclecontractilityS.SırrıBilge,MustafaSuatBolat,ArzuErdalAğrı,FikretErdemir,EkremAkdeniz,FatihFırat,ÖmerAlıcı

P079 TheeffectofatorvastatinandgemfibrozilonmousecorpuscavernosumtissueIlknurErkoseoglu,MineKadıogluDuman,MerveSaglam,ErsinYarıs,MuratSabriKesim,NuriIhsanKalyoncu

P080 ChroniceffectsofatypicantipsychoticsonvasdeferenscontractionsinmiceMehmetHanifiTanyeri,MehmetEminBuyukokuroglu,PelinTanyeri,OğuzMutlu,GünerUlak,FüruzanYıldızAkar,FarukErden

P081 TheeffectsofFerulaeleaochytrisrootextractonerectiledysfunctionindiabeticratsNadireEser,H.SinemBüyüknacar,ÖzgeÖztürkÇimentepe,YılmazUçar,CemilGöçmen,EdaKumcu

POSTER SESSIONS

49

P082 InvestigationconcerningprotectiveandtherapeuticeffectsofagomelatineonrenalischemiareperfusioninjuryinratsOnuralOzhan,HakanParlakpinar,OrhanTurfan,MehmetDemir,AlaaddinPolat,AhmetAcet

P083 Effectsoflong-termtreatmentwithpaliperidone,iloperidoneandloxapineonmiceisolatedvasdeferensMehmetHanifiTanyeri,MehmetEminBuyukokuroglu,PelinTanyeri,OğuzMutlu,GünerUlak,FüruzanYıldızAkar,FarukErden

P084 DecorinadministrationimprovesbladderfunctioninpartialbladderoutletobstructioninrabbitsOguzhanYildiz,MelikSeyrek,KemalGokhanUlusoy,EnginKaya,YusufKibar,SercanYilmaz,TurgayEbiloglu,AyhanOzcan

P085 Protectiveandtherapeuticeffectsofdexpanthenolonisoproterenol-inducedrenaldamageinratsHakanParlakpinar,FerhatKalkan,AlaaddinPolat,AhmetAcet

P086 RetrospectiveevaluationofpregnantwomenconsultedbecauseofdrugexposureduringpregnancyIremCavusoglu,MineKadioglu,IlknurErkoseoglu,TurhanAran,MehmetArmaganOsmanagaoglu,EnginYenilmez,SabriMuratKesim,ErsinYaris,NuriKalyoncu

P087 MedroxyprogesteroneacetateuseinpregnancyIremCavusoglu,IlknurErkoseoglu,MineKadioglu,TurhanAran,MehmetArmaganOsmanagaoglu,EnginYenilmez,SabriMuratKesim,ErsinYaris,NuriKalyoncu

P088 TheinfluenceofrisperidoneandolanzapineonvasdeferensinmiceMehmetHanifiTanyeri,MehmetEminBuyukokuroglu,PelinTanyeri,OğuzMutlu,GünerUlak,FüruzanYıldızAkar,FarukErden

P089 Theeffectsofdehydroepiandrosteroneandresveratrolonovarianandendometrialmorphology,serumhormone,oxidantandantioxidantlevelsinprimaryovarianfailure-inducedratsYaseminÖzatik,OrhanÖzatik,SemraYiğitaslan,BilginKaygısız,KevserErol

P090 EffectofafructoserichdietonvasdeferenscontractilityofratsS.SırrıBilge,EkremAkdeniz,MustafaSuatBolat,FatihFırat,ArzuErdalAğrı,ÖmerAlıcı,ÖnderÇınar,FikretErdemir

Veterinary PharmacologyP091 Cardiacsafetyofgamithromycininewes

OrhanCorum,BurakDik,EmreBahcivan,HaticeEser,AyseEr,EnverYazarP092 Effectofdexamethasoneonbloodthiobarbituricacidreactivesubstancesand

13,14-dihydro-15-keto-prostaglandin-F2αlevelsAyseEr,OrhanCorum,HaticeEser,EmreBahcivan,BurakDik,EnverYazar

POSTER SESSIONS

50

Poster Session Day 2, Tuesday, 28th June 2016, Poster Hall 15:00-16:30

Pain and InflammationP093 Theroleofopioidergicmechanismsontheanti-allodynicandantihyperalgesiceffectof

valnoctamideinratsNurcanBektasTurkmen,RanaArslan,DilaraNemutlu,SuleAydin

P094 AssessmentoftheantinociceptiveeffectoflevetiracetaminaratcraniotomypainmodelGeorgiaTsaousi,ChryssaPourzitaki,EvangeliaMavrantoni,KonstantinosKapanidis,DorotheaKapoukranidou,DimitriosKouvelas

P095 SerumcalciumlevelscorrelatewithserumcartilageoligomericmatrixproteinlevelsinkneeosteoarthritispatientsNyiMekarSaptarini,MarliaSinggihWibowo,TutusGusdinarGusdinar

P096 Investigationoflocalandsystemicinjectedbone-marrowderivedmesenchymalstemcellsoncoldallodyniaandelectrophysiologicparametersinmononeuropathicmiceOlcayErgürhanKıroğlu,ArashAlizadehYegani,ErkanMaytalman,MustafaEmre,FaziletAksu

P097 ContributionofplateletP2Y12receptorstochronicinflammatorypainKatinkaBekö,BenceKoványi,GergelyHorváth,ÁdámDénes,ZsuzsannaKörnyei,BálintBotz,ZsuzsannaHelyes,ChristaElisabethMüller,BeátaSperlágh

P098 Anti-inflammatoryactivityofneurotensin-peptidehybridinmurinemodelofcontactsensitivityresponseKatarzynaKaczynska,EwelinaKogut,DominikaZajac,MonikaJampolska,DorotaSulejczak,AndrzejLipkowski,PatrycjaKleczkowska

P099 Effectsofnociceptinreceptorantagonismonexperimentally-inducedscratchingbehaviorinmiceKubraDuvanAydemir,OzgurGunduz,AhmetUlugol

P100 Contributionofnociceptin/orphaninFQreceptorstotheantinociceptiveandhypothermiceffectsofdipyroneIsmetHandeErtin,OzgurGunduz,AhmetUlugol

P101 InvolvementofdescendingserotonergicandnoradrenergicsystemsandtheirspinalreceptorsubtypesintheantinociceptiveeffectofdipyroneAynurGencer,OzgurGunduz,AhmetUlugol

P102 HistopathologicalcharacteristicsofsciaticnerveandsoleusmuscletissuesafterlocalandsystemicadministrationofmesenchymalstemcellsinmononeuropathicmiceOlcayKıroğlu,ArashAlizadehYegani,ErkanMaytalman,KübraDemirkol,SuzanZorludemir,FaziletAksu

P103 Theantinociceptiveeffectofintravenouspregabalinincolorectaldistension-inducedvisceralpaininratsHasanGüzel,S.SırrıBilge,HakanBalcı,BaharAkyüz,DenizGündoğduArslan,FatihIlkaya,AyhanBozkurt

POSTER SESSIONS

51

P104 EffectofceftiofuronhyperalgesiaandallodyniainratneuropathicpainmodelandtheroleofimmuneprocessesonthiseffectRecepSelimŞentürk,AytülÖnal,SibelÜlker,DenizCoşkunsever,FatmaGülÇelenk,SelviNalbant

P105 Theeffectsofsilvernanoparticlesandgrapheneinducedwithelectro-magneticfieldsonhumanandbacterialcellsAlmaAkhmetova,TimurSaliev,DinaraBaiskhanova,MarsAkishev,GulsimKulsharova,DinaraBegimbetova,TalgatNurgozhin,SergeyMikhalovsky

P106 ThespecificactivityofvaginalsuppositoriesbasedprobioticconsortiumZhanagulKhassenbekova,AlexanderGulyayev,AlmagulKushugulova,SauleSaduakhasova,SamatKozhakhmetov,MairaUrasova,ShynggysSergazy,TalgatNurgozhin

P107 Effectsofagmatineoncisplatin-inducedneuropathyandneurotoxicityBilginKaygisiz,CigdemCengelli,SuleAydin,BasakDonertas,EnginYildirim,EmelUlupinar,KevserErol

P108 Effectsofanandamideoncisplatin-inducedneuropathyandneurotoxicityBilginKaygisiz,BasakDonertas,SuleAydin,CigdemCengelli,EnginYildirim,EmelUlupinar,KevserErol

P109 Laboratorydataandmannose-bindinglectincharacteristicsinTurkishchildrenwithahistoryofacuterheumaticfeverrelatedcarditisOnurGokhanYildirim,AyhanPektas,HalitBugraKoca,SerkanKurtgoz,MehmetBilgehanPektas

P110 AntiinflamatoryeffectofcarvacroloncottonpelletgranulomatestAyçaÇakmak,SuleymanAydin

P111 EfficacyofpulsedradiofrequencytherapytodorsalrootganglionaddingtotranscutaneouselectricalnervestimulationandexerciseforpersistentpainaftertotalkneearthroplastyIlknurAlbayrak,SezaApiliogullari,ÇağatayNusretDal,FundaLevendoğlu,ÖnderMuratÖzerbil

P112 Pulsedradiofrequencyappliedtothedorsalrootgangliafortreatmentofpost-strokecomplexregionalpainsyndrome:acaseseriesIlknurAlbayrak,SezaApiliogullari,ÖzkanÖnal,CengizhanGüngör,AliSaltalı,FundaLevendoğlu

P113 Ethanolextractofcumin(CuminumcyminumL.)seedsinhibitedlipopolysaccharide-inducedinflammatoryresponsesinRaw264.7cellsOrucAllahverdiyev,MehmetBerköz,MetinYıldırım,SerapYalın

Neuropharmacology / PsychopharmacologyP114 Effectsofcarbamazepine(CBZ)and/orphenytoin(PHE)onliverenzymesandureain

WistarRatsHadizaAliyu,JosephOAyo,SuleimanFAmbali,MuhammedMSuleiman,MuhammedTauheed,PeterOYusuf,HamzaIsa

POSTER SESSIONS

52

P115 AlterationsinbrainenergymetabolismfollowingacuteadministrationofL-glutamateGNageshBabu

P116 Nitricoxidesynthesis(NOS)inhibitorsdecreaseglobalDNAmethylationintheventralhippocampusofratssubmittedtolearnedhelplessnessIzaqueDeSousaMaciel,AmandaJulianaSales,SamiaR.L.Joca

P117 Pregabalinhasanatypicalprofileofanxiolytic-likeactivityinrodentsVincentCastagné

P118 Effectsofasenapineandpaliperidononanalgesyandlocomotion:AlteredgenexpressionlevelsofFGF2,synapsinandNGFinthehippocampusofmiceEsenGümüşlü,OğuzMutlu,GünerUlak,FüruzanYıldızAkar,FarukErden,HavvaKaya,IpekK.Çelikyurt,PelinTanyeri

P119 EffectsofselectivePDE-2InhibitorBAY60-7550,PDE-5inhibitorsildenafilandPDE-9inhibitorPF-04447943onlearningandmemoryintheMorriswatermazetestinnaivemiceEmineBektaş,FuruzanYıldızAkar,OğuzMutlu,GünerUlak,FarukErden

P120 EffectsofhippocampalhistoneacetylationandHDACinhibitiononspatiallearningandmemoryintheMorriswatermazeinratsRuhanDenizTopuz,OzgurGunduz,EbruTastekin,CetinHakanKaradag

P121 EffectsofrufinamideonspatialandavoidancememoryinMorriswatermaze,elevatedplusmazeandpassiveavoidancetestsinmiceIpekKomsuogluCelikyurt,LemanHuseynova,OguzMutlu,GunerUlak,FuruzanYildizAkar,FarukErden

P122 EffectsofretigabineandlacosamideonacquisitionandretrievalofmemoryinnaivemiceLemanHuseynova,IpekKomsuogluCelikyurt,OguzMutlu,GunerUlak,FuruzanYildizAkar,FarukErden

P123 TheEffectsofKaiXinSanonthecognitivedeficitsandpathologicalchangesofhippocampusinAPP/PS1doubletransgenicmiceFangFang,RanWang,YaqiDi,JingquanZhang,XuxingSang

P124 ComparisonoftheeffectsofvareniclineandbupropionontheconditionedplacepreferencetestwhichisinducedbymorphineinratsOrucAllahverdiyev,ÇağlaKarakulak,AndleebShahzadi,SibelÖzyazgan,BülentDemir,BurakÖnal,AhmetGökhanAkkan

P125 EffectsofKaiXinSanonhippocampalsynapticplasticityinAPP/PS1doubletransgenicmiceYaqiDi,FangFang,RanWang,XuxingSang,JingquanZhang

P126 Effectoflearnedhelplessnessonspinesynapsedensityinthedentategyrus.SuggestedroleofP2X7receptorAgnesKittel,LillaOtrokocsi,FlóraGölöncsér,BeátaSperlágh

P127 TheeffectofGLT-1transporteractivationonlearningandmemoryImpairmentinMorriswatermazeinducedbyscopolamineinratsBirgülÖzdemirHoxha,RuhanDenizTopuz,ÖzgürGündüz,AhmetUlugöl,ÇetinHakanKaradağ

POSTER SESSIONS

53

P128 DeterminationofthechangesinPP1,BDNFandReelingeneexpressionsinhippocampusduringspatiallearningandmemoryinmorriswatermazeinratsFatmaCeydaKorucu,CetinHakanKaradag

P129 Investigationofantidepressant-likeeffectofdipyroneinforcedswimmingtestKübraDemirkol,OlcayErgürhanKıroğlu,ArashAlizadehYegani,EmineEkemen,FatihBerktaş,FaziletAksu

P130 TheeffectsofaGinkgobilobaextractonextinctionandrelapseofethanol-inducedconditionedplacepreferenceinmiceOrucAllahverdiyev,KamandarYaqubov

P131 StandardizedmethanolicextractofCuscutareflexacausedphenelzinelikeactionsinanimalmodelsofdepressionSaraZeeshan,WahidZada,GhulamAbbas

P132 FamotidinereversessocialwithdrawalbutnotfearconditioningdeficitsinducedbyacuteketaminemodelinratsFeyzaAricioglu,GökhanÜnal,AyşeNurHazar,CerenŞahin,RümeysaKeleş

P133 PreclinicalresearchoffocalmusclehyperactivitydisordersbyclostridialneurotoxinsIvicaMatak,MajaRelja,ZdravkoLackovic

P134 OptimizingeffectsofbotulinumtoxintreatmentbypostinjectionactivityMajaRelja,MarinaMaravic,IvanaJurjevic,IvicaMatak

P135 ComparisonofglutamicaciddecarboxylaseimmunoreactivityinsubstantianigraparsreticulatebetweengeneticabsenceepilepticratsandnonepilepticcontrolratsMedineGulcebi,OzlemAkman,NihanCarcak,TugbaEryigit,FilizOnat

P136 Effectsofdiphenhydramineonlong-termpotentiationinhealthyandREMsleepdeprivedratsSadikTaskinTas,MetinYesiltepe,MehmetYildirimSara

P137 EffectsofmodafinilonMDMA-inducedspatialmemoryimpairmentRayhanehShariatmadari,MohammadSharifzadeh

P138 Theeffectsofdoxycyclineagainstchronicstress-inducedanxietyinratsUlyaKeskin,OğuzhanEkinEfe,ErkanErmis,SedaCal,SabanRemziErdem

P139 Protectiveeffectsofmelatoninagainst2,3,7,8-Tetrachlorodibenzo-p-dioxin-inducedbraininjuryinratsHakanParlakpinar,MustafaSagir,OsmanCiftci

P140 TheeffectoforphenadrineonmorphineinducedconditionedplacepreferenceCaglaKarakulak,AndleebShahzadi,OrucAllahverdiyev,AhmetGokhanAkkan,SibelOzyazgan

P141 DiabeticconditionsaltersinsulindegradingenzymelevelsInciKazkayasi,NihanBurulBozkurt,SerdarUma,AngelCedazoMinguez

P142 Plasmacorticosteronelevelsinbehaviouralmodel-inducedstressinratsPınarYamantürkÇelik,HüseyinTonyalı,SelçukŞen,YağızÜresin

POSTER SESSIONS

54

P143 Scopolamine-inducedconvulsionsinfastedmiceafterfoodintake:InvolvementofnitrergicsystemPınarYamantürkÇelik,HanifeRahmanlar,ZeynepGüneşÖzünal

P144 GABAAreceptoragonistmuscimolatsuperlowdosesimprovesspatialmemoryandpreventsNeuroinflammationinanon-transgenicratAD-typemodelJolantaUpite,KarinaNarbute,UlrikaBeitnere,VladimirsPilipenko,ZaneDzirkale,JurisRumaks,BaibaJansone,VijaKlusa

P145 ComparisonoftheeffectsofthreedifferentPDEinhibitors,sildenafil,BAY60-7550andPF-04447943onfearmemoryinthefearconditioningtestinmiceEmineBektaş,FuruzanYıldızAkar,OğuzMutlu,GünerUlak,FarukErden

P146 InvestigationofsomecentralactivitiesoffreshleafessentialoilofLantanacamarainmiceIdrisAjayiOyemitan,OluwatayoBenedictOlowolafe,TosinMaxwellOlaleye,AdebolaOmowumiOyedeji

P147 AntipsychoticsdecreasedtheuptakeofdietaryantioxidantquercetinintoneonatalratastrocytesMojcaKrzan,LanaNovic;,LucijaNovak,LovroZiberna

P148 TheevaluationoftheneurotoxiceffectsoflevosimendanonneuroblastomacellsTülünÖztürk,KamilVural,BedirhanAy,IşılAydemir

Cancer ChemotherapyP149 Theeffectofmetforminaloneandincombinationwith5-fluorouracilandoxaliplatinon

humanHT-29coloncancercelllineEzgiBozkurt,RecepBayram,ÖzgeUzun

P150 ComparisonofanticanceractivityofhydroalcoholicextractsofCurcumalongaL,PeganumharmalaLandBoswelliaserrataonHeLacelllineFarzanehFarajianMashhadi,SaeedehSalimi,ForoozanForoozandeh,NooshinNaghsh

P151 CytotoxicactivityofthealkaloidsfromthestemofXylopialaevigataDanielPereiraBezerra,LeocileyRochaAlencarMenezes,CinaraOliveiraD’sousaCosta,AnaCarolinaBorgesDaCruzRodrigues,FelipeRosárioDoEspiritoSanto,AngelitaNepel,LíviaMacedoDutra,FelipeMouraAraujoSilva,MilenaBotelhoPereiraSoares,AnderssonBarison,EmmanoelVilaçaCosta

P152 EhrlichAscitesCarcinoma:oneofthemostlucidcelllinestocarryoutin-vitroanticancerresearch-areviewAnuragChanda

P153 ApoptoticandcytotoxiceffectsofPistaciaveranutextractonhumanhepatocellularcarcinomacelllineSNU-423AbdullahTuncayDemiryurek,EbruTemiz,AhmetSaracaloglu,SerdarOztuzcu,SenizDemiryurek,BilgeSener,BeyhanCengiz,MustafaUlasli,CelaletdinCamci

P154 AnticancereffectsofcannabinoidagonistsACEAandL-759656onMCF-7breastcancercelllineandHUVECNergizHacerTurgut,AhmetAltun,MuhammedMucahitCicek,MerveErgul,BulentSarac

POSTER SESSIONS

55

P155 AnticancereffectsofRhokinaseinhibitorsAS1892802andFasudilhydrochlorideonMCF-7breastcancercelllineandHUVECAhmetAltun,NergizHacerTurgut,MuhammedMucahidCicek,MerveErgul,BulentSarac

P156 ProtectiveandtherapeuticeffectsofmolsidomineonretinopathyandoxidativestressinducedbyradiotheraphyinrateyesHakanParlakpinar,MuratAtabeyOzer,NihatPolat,KemalEkici,AlaaddinPolat,SerkanOzen

P157 ANovelHSP90Inhibitor,PU-H71DecreasesTumorGrowthandAltersAnti-tumoralImmuneResponseinMetastaticBreastCarcinomaModelŞuleKale,NurayErin

P158 PU-H71andradiotherapyincombinationdecreasestumorgrowthandlungmetastasisinmetastaticbreastcarcinomamodelŞuleKale,AylinFidanKorcum,YiğitÇeçen,NurayErin

P159 EffectsofalfacalcidolandcalcitrioloncellproliferationinHEC1AendometrialadenocarcinomacellsIbrahimDuman,IsmailÜn,RukiyeNalanTiftik

P160 AmetaanalysisforcomparisonefficacyandsafetyofepidermalgrowthfactorreceptorinhibitorscetuximabandpanitumumabManolyaKıvılcım,IlkerEtikan,NurettinAbacıoglu,BilgenBasgut

ImmunopharmacologyP161 Erythrocyteghosts’influenceonthephenotypicplasticityofmacrophage

ZhanagulKhassenbekova,GulyayevAlexandr,ShynggysSergazy,YermekbayevaBakytgul,NurgozhinTalgat,ZhumadilovZhaxybay

P162 OuterMembraneVesicles(OMVs)secretedbyprobioticEscherichiacoliNissle1917:effectsonchronicexperimentalcolitisinducedbydextransulfatesodium(DSS)inmiceMaríaJoséFábrega,AlbaRodríguez,FrancescaAlgieri,JosefaBadía,RosaGiménez,JulioGálvez,LauraBaldomà

P163 Intestinalanti-inflammatoryeffectofSaturejaobovataextractintheTNBSmodelofratcolitisFrancescaAlgieri,TeresaVezza,AlbaRodríguez,MaríaPilarUtrilla,MaríaReyesGonzálezTejero,ManuelCasaresPorcel,JoaquínMoleroMesa,MaríaElenaRodríguezCabezas,JulioGálvez

P164 NK2receptorbutnotNK1receptorantagonist(GR159897,RP67580)increasesreleaseofangiogenicchemokinefrombreastcarcinomaEsraNizam,NurayErin

P165 In-vivoeffectsofNK1andNK2receptorantagonistsonmetastaticbreastcarcinomaEsraNizam,NurayErin,GamzeTanröver

POSTER SESSIONS

56

P166 Dietarygalacto-oligosaccharidesimprovebudesonidetreatmentefficacyinhousedustmite-inducedasthmainmicebyenhancingsuppressionofpulmonaryTh2drivingmediatorsKimA.t.Verheijden,SaskiaBraber,TheaLeusinkMuis,PrescillaV.Jeurink,SuzanThijssen,AlettaD.Kraneveld,JohanGarssen,GertFolkerts,LinetteE.m.Willemsen

P167 Theroleofurotensin-IIanditsreceptorsinsepsisinducedlunginjuryunderdiabeticconditionsRustemAnilUgan,ElifCadirci,ZekaiHalici,ErdemToktay,IrfanCinar

Drugs for Infectious DiseasesP168 EvaluationoftheantibacterialactivityofthesolventfractionsoftheleavesofRhamnus

prinoidesL’Herit(Rhamnaceae)YalewMolla,TeshomeNedi,GetachewTadesse,HaileAlemayehu,WorkinehShibeshi

P169 InVitroSusceptibilityPatternsofClinicallyImportantTrichophyton,MicrosporiumandEpidermophytonSpeciesAgainstFourAntifungalDrugsMineAydınKurç,AyşeDemetKaya,GamzeErfan

P170 Analtenativeregimeforthetreatmentofneurobrucellosis:tigecyclinecombinationMuratYeşilyurt,AyşeDemetKaya,MineAydınKurç

P171 Effectsofpioglitazone,aagonistofppar-gamma,onmesentericbloodflowandorgandamageinanexperimentalsepticshockErdemKamilOzer,AlperBektasIskit,MustafaIlhan

P172 EffectsofPTDC,aninhibitörofNF-κB,onmesentericbloodflowandorgandamageinanexperimentalsepticshockErdemKamilOzer,AlperBektasIskit,MustafaIlhan

P173 Effectsofgenistein,atyrosinekinaseinhibitor,onmesentericbloodflowandorgandamageinanexperimentalsepticshockErdemKamilOzer,AlperBektasIskit,MustafaIlhan

P174 Preventiveeffectsofthymoquinoneonsurvival,vasculardysfunctionandtissueinjuryinsepsisErdemKamilOzer,MustafaTugrulGoktas,AysunToker

Imaging TechnicsP175 EvaluationofpossiblecytotoxiceffectsofVanadiumpentoxideoncoloncarcinomacell

linewitharealtimeanalyserEbruÖztürk,AlimHüseyinDokumacı,AyşeKübraKaraboğaArslan,MükerremBetülYererAycan

P176 Real-timexCELLigenceimpedanceanalysisofthecytotoxicityofvanadiumpentoxideonnormalhumanfibroblastandMCF-7cellsAyşeKübraKaraboğaArslan,EbruÖztürk,AlimHüseyinDokumacı,MükerremBetülYererAycan

P177 CytotoxiceffectsofnoveloxadiazolederivativesonMCF-7breastcancercelllineEbruÖztürk,SedatGülay,TuğçeÖzyazıcı,MarvaBader,MükerremBetülYererAycan,MeriçKöksalAkkoç

POSTER SESSIONS

57

Pharmacology EducationP178 KazakhstanNationalMedicinesFormulary:buildinganevidence-basedcultureusing

expertresourcesandnetworksDuncanEnright,DavidWoods,NataliaCebotarenco,KrystynaJoyce

P179 Objectivestructuredclinicalexaminations(OSCE)improvedcommunicationskillsofstudentofpharmacologyinmedicineandpodiatrydegreeInmaculadaBellido,EncarnaciónBlanco,AurelioGomezLuque

P180 Erythropoietinacceleratestumorgrowththroughincreaseoferythropoietinreceptor(EpoR)invitroandvivoaswellasvascularendothelialgrowthfactorreceptor(Flt-1)expressioninDLD-1andHt-29xenograftsAnnaTankiewicz-Kwedlo,JustynaMagdalenaHermanowicz,ArkadiuszSurazynski,DariuszRozkiewicz,AnnaPryczynicz,KrystynaPawlak,TomaszDomaniewski,DariuszPawlak

P181 EvaluationofPatients’AttitudesRegardingMedicineUseforDentalHealthProblemsCenkerZekiKoyuncuoglu,NerimanIpekKirmizi,IlaydaCeylan,BahattinSaz,AhmetAkici

P182 AnevaluationofknowledgeandattitudesofsecondyearstudentsofAkdenizUniversityMedicalFacultyaboutrationaldruguseZelihaBayram,DevrimDemirDora

P183 Investigationtheuseofover-the-counterandherbalmedicationinaTurkishuniversitypopulationSevimAksoyKartcı,ÇiğdemApaydınKayaPoster Session Day 3, Wednesday, 29th June 2016, Poster Hall 15:00-16:30

Pharmacokinetics and Drug MetabolismP184 BioavailabilityandmetabolismproductsofandrographolideinA23187induced-rabbit

JuttiLevita,TantiJuwita,SelmaRamadhani,NyiMekarSaptarini,MutakinMutakinP185 P-glycoproteinmediatedpharmacokineticinteractionbetweentalinololandbarnidipine

NarinOzturk,DilekOzturk,ZelihaPalaKara,AlperOkyarP186 Sexfactorsinthepharmacokineticsofitoprideinhealthyhumanvolunteers

JiriKopecky,ZbynekSvoboda,JanaZoulova,IvanaZubata,LibuseSmetanovaP187 Thefrequencyofmonitoringphenytointherapeuticconcentrationrangeandre-evaluation

ofthecorrectedphenytoinlevelsEmineKaratasKocberber,DenizKızılaslan,CemErdogan,BarkınBerk

P188 Pharmacokineticsofopioidsinchroniclowbackpain(CLBP)treatment:preliminarydataoncytochromep4502D6(CYP2D6)ConcettaDagostino,MassimoAllegri,SilvanaMontella,CarlottaVellucci,AriannaMontali,MarcoBaciarello,MaurizioMarchesini,ChristianAngelCompagnone,GuidoFanelli

POSTER SESSIONS

58

P189 Clopidogrelmarkedlyincreasestheplasmaconcentrationsofpioglitazone:evidenceforstronginhibitionofCYP2C8byclopidogrelMattiKItkonen,AleksiTornio,MikkoNeuvonen,PerttiJNeuvonen,MikkoNiemi,JanneTBackman

P190 PredictionofCYP2D6phenotypefromtherisperidoneanditsactivemetabolite9-OH-risperidoneconcentrationratioinchildrenwithconductdisordersHavvaNuketIsiten,SuleGok,SelmaOzilhan,FadimeCanbolat,NevzatTarhan

P191 β-adrenoceptormediatedantiproliferativeeffectinMB231breastcancercellsdoesnotdependontheinhibitionofextracellularregulatedkinase1/2activityMatildaMerveTuğlu,GözdeÖzyön,HakanGürdal

Clinical PharmacologyP192 Theeffectsoftheantiepilepticdrugsonthelevelsofthyroidhormones,VitaminB12and

folateNerminBolukbasi,OkanBolukbasi,FerdaAkar

P193 UtilizationofgenericsinantipsychoticprescribingforoutpatientsofAHEPAhospitalinGreeceduringtheyearsoffinancialcrisisParaskeviPapaioannidou,NikolaosP.Moschopoulos,PaschalinaKasviki,IoannisNimatoudis

P194 TrendsingenericuseofantidepressantsduringthefinancialcrisisinGreeceParaskeviPapaioannidou,MariaMichailidou,StamatiaMichailidou,AchilleasNtaralas

P195 Nurses’knowledge,opinionsandattitudestowardclinicalresearch–acrosssectionalsurveyatDokuzEylulUniversityHospitalHacerBulutAksoy,MAylinArici,ReyhanUcku,AyseGelal

P196 PharmacovigilanceperceptionandadversedrugreactionreportingofphysiciansinanuniversityhospitalMukaddesGumustekin,M.AylinArici,PelinOzkan,AyseGelal,YesimTuncok

P197 UseofhormonalcontraceptivesinThessaloniki,GreeceParaskeviPapaioannidou,MariaMichailidou,AchilleasNtaralas

P198 HypoglycemicpropertiesofpolyphenolconcentratefromCabernetSauvignoncollectionofgrapesofKazakhstanregiononthemodelofalloxaninduceddiabetesinratsShynggysSergazy,GulyayevAlexandr,ShulgauZarina,NurgozhinTalgat

P199 ClinicaltrialsinTurkeyregisteredatclinicaltrials.govZelihaBayram,AsenaAyseGenc,BuketGüngör

P200 Whatistheadditionalmonitoringdrugs?ZelihaBayram,AsenaAyseGenc,BuketGüngör

P201 RationaluseofmethylphenidateinADHDinUmraniye,IstanbulIsaBadur

P202 Self-medicationpracticeswithantibioticsamongGreekmedicalstudentsChryssaPourzitaki,GeorgiosPapazisis,GeorgiaTsaousi,GeorgiosGeropoulos,ChristosDrosos,EiriniApostolidou,ChrysanthiSardeli,DimitriosKouvelas

POSTER SESSIONS

59

P203 Evaluationofpotentialdrug–druginteractionsincardiovascularsurgeryintensivecareunitpatientsBernaTerzioğluBebitoğlu,MuratUğur,CevdetKoçoğulları,MehmetEren

P204 AssessmentofdrugsthatmayprolongQTand/orcausetorsadesdepointesintheintensivecareunitpatientsofauniversityhospitalNesrinÇağlayanDuman,MedineİdrisoğluGülçebi,BeycanGözdeAyhan,SongülÖzkula,ZehraNurTurganAşık,RezzanGülhan,FilizOnat,MehmetZaferGören,AtilaKaraalp

P205 Venlafaxinesideeffectsonurogenitalsystemcausedearlydiagnosisofprostatecancer:AcasereportAyseParlarGurkan,AhmetAyer

P206 AntipsychoticprescribingforinpatientsofAHEPAhospitalinGreeceParaskeviPapaioannidou,PaschalinaKasviki,NikolaosP.Moschopoulos,IoannisNimatoudis

P207 UseofantihypertensivesinThessaloniki,GreeceParaskeviPapaioannidou,MariaMichailidou,StamatiaMichailidou

P208 EvaluationoftheeffectoflemonjuiceonbloodpressureinhypertensivepatientsZeynepGunesOzunal,IlirianaAlloqiTahirbegolli,YagizUresin

P209 Drugexposurebeforeand/orduringpregnancy:Take-homemessagesfromsmalldataPınarYamantürkÇelik,IlirianaAlloqiTahirbegolli,BetülSayın,ZeynepGüneşÖzünal

P210 Evaluationofpotentialdrug-druginteractionamongtheendstagerenalfailurepatientofCerrahpasaMedicalFacultyNephrologyTransplantUnitIkbalSonmez,AndleebShahzadi,CaglaKarakulak,SelmaAlagoz,NurhanSeyahi,AhmetGokhanAkkan

P211 AcomparativestudyonefficacyofpolymyxinB,neomycinandpolymyxinB,neomycin,hydrocortisoneinthetreatmentofotitisexternaMayuriGupta

Pharmacology in Special PopulationsP212 Theriskofdruginteractionandpolypharmacyingeriatricpatients

EmineKaratasKocberber,MerveMutlu,BusraMancar,NedaTaner,BusraNurCattık,BarkınBerk

P213 ExposuretoSSRIandSNRIantidepressantsduringpregnancy:riskoffetusornewbornGozdeAyhan,MedineGulcebi,NesrinDuman,SongulOzkula,ZehraAsik,RezzanGulhan,AtilaKaraalp,FilizOnat,ZaferGoren

P214 ImmunosupressivedrugcounselingforpregnancyinpatientswithsolidorgantransplantandfetaloutcomeSongulOzkula,ZehraAsik,NesrinDuman,GozdeAyhan,MedineGulcebi,AtilaKaraaalp,FilizOnat,ZaferGoren,RezzanGulhan

POSTER SESSIONS

60

Pharmacogenetics / PharmacogenomicsP215 PharmacokineticandpharmacodynamicanalysisofglimepiridewithCYP2C9genetic

polymorphisminhealthyKoreanSubjectsYongBokLee,HeaYoungCho

P216 FrequenciesofCYP2E1andALDH2allelesandgenotypesinTurkishheadandneckcancerpopulationMetinDenizKarakoç,SelimKortunay,AylinKoseler,CüneytOrhanKara,BülentTopuz

P217 FrequenciesofP2RX7allelesandgenotypesinaTurkishAlzheimer’sdiseasepopulationSelimKortunay,AylinKoseler,MelekTunçAta,ÇağatayHilmiÖncel,YükselSandıkçı,SebahatTurgut

P218 InvestigationoftheassociationbetweenTRPM7genepolymorphismandpretermbirthBelginAlaşehirli,ŞenizDemiryürek,ReyhanGündüz,SerdarÖztuzcu,ElifOğuz,MeteGürolUğur,AbdullahTuncayDemiryürek

P219 Lackofassociationbetweeninsulin-likegrowthfactor-1receptorpolymorphismandAlzheimer’sdiseaseSelimKortunay,MelekTunçAta,ÇağatayHilmiÖncel,ŞeymaÖzkan,YükselSandıkçı,SebahatTurgut

P220 EffectsofaCYP3A4inhibitoronthepharmacokineticsoftramadolinrelationtoCYP2D6genotypeSeHyungKim,YoungHoonKim,JiYeongByeon,HyunJeeLee,DongHyunKim,HyeJinLim,ChoongMinLee,SeokYongLee

P221 CoadministrationofaCYP3A4inhibitorandrisperidoneinrelationtoCYP2D6genotypeSeHyungKim,YoungHoonKim,JiYeongByeon,HyunJeeLee,DongHyunKim,HyeJinLim,ChoongMinLee,SeokYongLee

P222 EffectofCYP2D6*10alleleonthepharmacokineticparametersoftolterodineSeHyungKim,YoungHoonKim,JiYeongByeon,HyunJeeLee,DongHyunKim,HyeJinLim,ChoongMinLee

P223 ThefrequencydistributionsofCYP3A4*22inTurkishpopulationIbrahimSerkanAvşar,MuradiyeNacak,MehmetEminErdal,NazanAydın,ŞuleGök,HasanHerken,ErsinYarış,EsraSağlam,AtillaBozkurt,ÜmitYaşar,ErtanAy,AhmetŞükrüAynacıoğlu

P224 AssociationwithCYP2C9polymorphisminheadandneckcancerAylinKoseler,SelimKortunay,MetinDenizKarakoç,CuneytOrhanKara,BulentTopuz

P225 TheroleofROCK1andROCK2genepolymorphismsinpreeclampsiaİbrahimSerkanAvşar,BelginAlaşehirli,ElifOğuz,SerdarÖztuzcu,ŞenizDemiryürek,ReyhanGündüz,MeteGürolUğur,AbdullahTuncayDemiryürek

POSTER SESSIONS

61

P226 InvestigationofreceptorofadvancedglycationendproductgenepolymorphismsincardiacsyndromeXpatientsBurakÖnal,SibelÖzyazgan,DenizÖzen,BülentDemir,AhmetGökhanAkkan

P227 AssociationofeNOS,iNOSgeneticpolymorphismswithdruginducedgingivalhyperplasiaErkanSukuroglu,AhmetMuderrisoglu,LokmanCevik,MustafaTGoktas,OzgurKaraca,UmitYasar,FerihaCaglayan,AtillaBozkurt,MelihOBabaoglu

P228 Associationofmultidrugresistanceprotein1(MDR1)withdruginducedgingivalhyperplasiaErkanSukuroglu,LokmanCevik,AhmetMuderrisoglu,MustafaTugrulGoktas,OzgurKaraca,MelihOnderBabaoglu,FerihaCaglayan,AtillaBozkurt,UmitYasar

P229 EvaluationofCYP2C19activityatcolchicinetreatedpatientsMustafaTuğrulGöktaş,SaidKalkışım,AliAkdoğan,MelihO.Babaoğlu,ÜmitYaşar,AtillaBozkurt

Drug Safety and ToxicologyP230 Antiproliferativeeffectofdoxorubicininfetalglomerularmesangialcells

TheresaAdebolaJohn,HiteshSoni,AdebowaleAdebiyiP231 Allergicresponseassessmentinimmunizedmicewitheffectiveadjuvantedtoxoid

NassrineBachsais,LilaBoussagAbib,FatimaLarabaDjebariP232 Theinvestigationofpossibleprotectiveeffectofmelatoninonoxidantinjuryin

streptozotocininduceddiabeticratsintestineGokselSener,LeventKabasakal,OzgeCevik,GizemBuseAkcay,CaglarMacit

P233 ProtectiveeffectofhypericumperforatumextractongentamicininducedneprotoxicityinmiceHalilMahirkaplan,ErginŞingirik,ArashAlizadehYegani,PercinPazarcı

P234 Protectiveeffectofalpha-LinolenicacidongentamicininducedneprotoxicityinmiceHalilMahirkaplan,ErginŞingirik,ArasAlizadehYegani,OlcayErgürhanKıroğlu

P235 AntipsychoticexposureinanemergencyserviceMAylinArici,AynurSahin,NeşeÇolakOray,BaşakBayram,YesimTuncok

P236 CardiacsafetyoflongactingmuscarinicreceptorantagonistsinthetreatmentofchronicobstructivepulmonarydiseaseShabanaCassambai,SadieDean,KatherineLHarvey,ChristopherJMee,AfthabHussain

P237 EffectsofprenatalcitalopramexposureonmotorfunctionandcoordinationofratoffspringAyşenurZaimoğlu,S.SırrıBilge,DenizGündoğduArslan,ÖzgeDarakcı,BaharAkyüz,ArzuErdalAğrı,AyhanBozkurt

P238 Thecomparisonofresveratrolandsilibinininpreventingalphaamanitin-inducedlivertoxicity:PreliminaryfindingsAynurSahin,OktayKesici,SuleKalkan,YesimTuncok,BekirUgurErgur,IlkayAksu,M.AylinArici

POSTER SESSIONS

62

P239 α1-andβ-adrenoceptormediatedtransactivationofepithelialgrowthfactorreceptorinDU145prostatecancercelllinesGözdeÖzyön,MatildaMerveTuğlu,BaşakDumanDalkılıç,HakanGurdal

P240 Contributionofrho/rho-kinasesignalisationpathwaytogentamicininducednephrotoxicityHalilMahirkaplan,ErginŞingirik,ArashAlizadehYegani

P241 AntioxidantprovocationofaspirinandvitaminCagainstconsumptionofcornsyruponratliverŞükriyeYeşilot,MehmetKayaÖzer,IbrahimAydınCandan,FatihGültekin

P242 Mayvitamincandaspirinbeprotectiveagainstpancreaticdamagecausedbyconsumptionofcornsyrup?ŞükriyeYeşilot,EkremÇiçek,BirsenHarunDağdeviren,MeralÖncü

P243 TheriskofdruginteractioninpatientstakingantihypertensivemedicationsEmineKaratasKocberber,AhmedOzler,SametAydemir,CengizhanCeylan,OzgeBadem,BarkınBerk

P244 TheriskofdruginteractioninhospitalizedpatientsusingclarithromycinCengizhanCeylan,EmineKaratasKocberber,NedaTaner,BarkınBerk

P245 Follow-upresultsofmaternalandpaternalexposuretoisotretioninZehraNurTurganAşık,SongülÖzkula,GözdeBeycanAyhan,NesrinDuman,MedineGülçebi,RezzanGülhan,AtilaKaraalp,FilizOnat

P246 Evaluationofenoxaparin-acetylsalicylicacidinteractionsusedinpatientsinintensivecareunitsSongulOzkula,MedineGulcebi,ZehraAsik,NesrinDuman,GozdeAyhan,AtilaKaraaalp,FilizOnat,RezzanGulhan

P247 Thelevelsofimmunosuppressivedrugs,tacrolimusandcyclosporine-ameasuredintherapeuticdrugmonitoringlaboratoryKemalGökhanUlusoy,MelikSeyrek,OğuzhanYıldız,EnisMacit

P248 Theprotectiveroleofresveratrolonserumtotalsialicacidandlipid-boundsialicacidinfemaleratswithchronicfluorosisGokhanOto,SuatEkin,HulyaOzdemir,MehmetBulduk,HasanUyar,ErsoyÖksüz

P249 DeterminationofMicrocystinToxininChroococcusminutusTunayKaran,ZekeriyaAltuner

P250 EffectsofprenatalsertralineexposureonmotorfunctionandcoordinationofratoffspringMahdiehMalekiSani,S.SırrıBilge,BaharAkyüz,HakanBalcı,ArzuErdalAğrı

P251 DoweknowenoughaboutantibioticsMirjanaJovanovicDjuraskovic,OliveraProdanovic,JelenaVelimirovic,TeodoraBiga

P252 Onthetoxicologyofdrugdeliverysystems:polyamidoaminedendrimersinhibitAngiotensinII-mediatedEGFRandErbB2transactivationSaghirAkhtar,AhmedZElHashim,BinduChandrasekhar,SreejaAttur,IbrahimFBenter

P253 EffectofhypericumperforatumextractongentamicininducedapoptosisinkidneyHalilMahirkaplan,VolkanIzol,IbrahimAtillaArıdoğan

POSTER SESSIONS

63

POSTER SESSIONSP254 Effectofalpha-linolenicacidongentamicininducedapoptosisinkidney

HalilMahirkaplan,VolkanIzol,IbrahimAtillaArıdoğanP255 Protectiveeffectofhypericumperforatumextractongentamicininducedototoxicity

HalilMahirkaplan,VolkanIzol,IbrahimAtillaArıdoğanP256 UroprotectiveefficacyofoleuropeincombinedMESNAincyclophosphamideinduced

hemorrhagiccystitisinratsYasinIlgaz,EsraErdogan,EminOztas

P257 RutinameliorateschemotherapeuticinducedhepaticinjuryinratsEsraErdogan,YasinIlgaz,PinarNaileGurgor,TurgutTopal,EminOztas

P258 EffectofCYP3A5and3A418BoncyclosporinelevelsonEgyptianrenaltransplantedpatientsGomaaMostafaHedeab,YasserHashad,AhmadFarag,AmrMohamad,InasLatif,SahierElkashab

Drug Discovery, Development and EvaluationP259 Asimpleandsensitivehigh-performanceliquidchromatographicmethodforthe

determinationofmitragynineinratplasmaandtissuesAmmarImadHazim,SurashRamanathan,SuhanyaParthasarathy,SharifMahsufiMansor

P260 HeijiangdanOintmentRelievesOxidativeStressfromRadiationDermatitisInducedby60Coγ-RayinratLinYang,XiaominWang

P261 Purification,biochemicalcharacterizationandproteomicidentificationofafibrinogenolyticandhemorrhagicmetalloproteinasefromCerastescerastesvenomHindaBoukhalfaAbib,FatimaLarabaDjebari

P262 ScreeningofcytotoxicactivityofselectedBrazilianNortheastmedicinalplantsDanielPereiraBezerra,TiagoR.Santos,CinaraO.D´sousaCosta,AlexandreF.C.Galvão,LarissaM.Bomfim,AnaC.B.DaC.Rodrigues,MauricioC.S.Mota,DantasA.Alex,MilenaB.P.Soares,ThiagoB.C.Silva

P263 TheeffectsofusodeoxycholicacidoncytotoxicactivityandproapoptoticpotentialofdoxorubicininMCF-7celllineBojanStanimirov,KarmenStankov,NebojšaPavlovic,MajaDjanic,VesnaKojic,IvaBarjaktarovic,MomirMikov

P264 EvaluationofbloodflowpromotingeffectandsafetyofarnicaHideakiMinamino,YoshiyukiObayashi,AkiraUchiyama,YutakaHirayama,KiyoAdachi

P265 Evaluationofvanadiumpentoxitecytotoxicityona549celllinewithanovelrealtimemethod:Xcelligence(RTCA)AlimHüseyinDokumacı,AyseKubraKarabogaArslan,EbruOzturk,MukerremBetulAycanYerer

P266 AntifungalactivityofjugloneencapsulatedPLGAnanoparticlesBusraSumayeKocyigit,TulinOzbekArasoglu,BusraGumus,GozdeYelkenci,SerapDerman,BanuMansuroglu,IsmailKocacaliskan

64

P267 BioflavonoidencapsulatedPLGAnanoparticlesagainstListeriamonocytogenesBusraGumus,TulinOzbekArasoglu,BusraSumayeKocyigit,DenizUzunoglu,BanuMansuroglu,SerapDerman

P268 HepatoprotectiveEffectsofScorzoneraL.SpeciesonCarbonTetrachloride-inducedLiverToxicityinRatsHanefiOzbek,OzlemBahadirAcikara,IlknurKeskin,NerimanIpekKirmizi,AyşeArzuSakul,TurkanYigitbasi,GulcinSaltan

P269 Real-timexCELLigencecellanalysisofRL95-2humanendometrialadenocarcinomacellsandthecytotoxicityofalpha-chaconineandalpha-solaninecompundsonRL95-2cellsAyşeKübraKaraboğaArslan,MükerremBetülYererAycan

P270 Anovelnaphthoquinonederivativeinhibitsviability,blockscellcycleprogressionandinducesapoptosisinhumanchronicmyelogenousleukemiacellsLeandroFernándezPérez,BorjaGuerra,PatriciaMartínRodríguez,JuanCarlosDíazChico,GrantMcnaughtonSmith,SaraJiménezAlonso,JuanCarlosMontero,RaquelBlanco,JavierLeón,AnaEstévezBraun,AtanasioPandiella,NicolásDíazChico

P271 HepatoprotectiveeffectofOpuntiarobustaandOpuntiastreptacanthafruitsagainstacetaminophen-inducedacuteliverdamageHersonAntonioGonzálezPonce,ManonBuistHoman,KlassNicoFaber,HanMoshage,MaríaConsolaciónMartínezSaldaña,FernandoJaramilloJuárez,AnaRosaRincónSanchez,MaríaTeresaSumayaMartínez

Biopharmaceuticals and BiosimilarsP272 Biochemicalcomposition,antioxidant,analgesicandanti-inflammatoryactivitiesof

OpuntiamicrodasyscladodesKhaoulaAdouni,HassibaChahdoura,LotfiAchour

P273 Biochemicalcomposition,analgesicandanti-inflammatoryactivitiesofOpuntiamicrodasysSeedsHassibaChahdoura,KhaoulaAdouni,LotfiAchour

P274 InvestigationofnorharmanepresenceinChroococcusminutusandGeitlerinemacarotinosumTunayKaran,ZekeriyaAltuner

P275 AntiproliferativeactivityofCladophorafracta(MüllerexVahl)KützingonHeLaandC6cellslinesTunayKaran,RamazanErenler

P276 OsteoprotectivepropertiesofRNA-containingdrugOsteochondrinSonosteoporoticratmodelZarinaShulgau,AlexandrGulyayev,ShynggysSergazy,NuriyaKenzhebayeva,BayanSagindykova,NurgozhinTalgat

POSTER SESSIONS

Author Index

65

Author IndexAuthor Index

66

Author indexTheauthorsarelistedassurname-nameformat.C001-C0120referoralpresentations.P001-P276referposterpresentations.

AbacıogluNurettin P160AbbasGhulam P131AbberingSuzanne C065AbboudDayana C003AbiaRocio C008,C015AbudayyakMahmoud P077AbueidLeyla P032AcetAhmet P082,P085AchourLotfi P272,P273AdachiKiyo P264AdebiyiAdebowale P230AdouniKhaoula P072,P272,P273AğrıArzuErdal P090AhmedDanish C063AkarFatma C071,P061AkarFerda P192AkarFuruzanYildiz P121,P122AkbariEsmaeil C035AkbasSedat C111AkbilekBatmazSibel C073AkcayGizemBuse P232AkdemirAtilla C112AkdenizEkrem P078,P090AkdoğanAli P229AkhayevaTamila C082AkhmetovaAlma P105AkhtarSaghir P252AkiciAhmet C052,C110,C054,

P181AkishevMars P105AkishevaAygulyaMayrova P064AkkanAhmetGökhan P043,P044,P124,

P140,P210,P226AkkoçHasan C020,P046AkmanOzlem P135AksoyKartcıSevim P183AksoyMesil C054AksoyUmit P006AksuFazilet P096,P102,P129

AksuIlkay P238AksuUğur C009AkyüzBahar P103,P237,P250AlFayoumiSuliman C049AlHumadiAhmed C041AlHumadiHussam C076AlagozSelma P210AlaşehirliBelgin C077,P218,P225AlbayrakAbdulmecit C096AlbayrakIlknur P111,P112AlemayehuHaile P168AlexDantasA. P262AlexanderGulyayev P013AlexandrGulyayev P161,P198AlgieriFrancesca C095,P074,P162,

P163AlhanÖzlem C109AlıcıÖmer P078,P090AlicanInci P032AliyuHadiza P114AlkanAli C110AllahverdiyevOruc C026,P113,P124,

P130,P140AllakondaLingesh C075,P071AllegriMassimo P188AlloqiTahirbegolliIliriana C073,P208,P209AlolabiReem C120AlpYıldırımFatoşIlkay P049,P055AltanVecdiMelih C012,C014AltınışıkHaticeBetül C119AltınışıkUğur C091AltunAhmet C017,C018,C100,

P154,P155AltunerZekeriya P249,P274AlvarezLaviadaAnita P036AlyuFeyza C068AmbaliSuleimanF P114AmbergSherri C049AndreadouIoanna C011,P038,P039,P042AnelKabdulina P013AnjumIrfan C020ApaydınKayaÇiğdem P183ApiliogullariSeza C087,C093,P111,P112ApostolidouEirini P202

AUTHOR INDEX

67

AUTHOR INDEXAppavooArulVelan C075ArababadiMohammadKazemi

C042

AranTurhan P086,P087ArıbasAlpay P027ArıdoğanIbrahimAtilla P253,P254,P255ArıkMuhammetKasım C091AriciM.Aylin P076,P195,P196,

P235,P238AriciogluFeyza P132AriogluInanEbru C012ArkMustafa C085ArslanRana P093ArunAslı P045ArunMehmetZuhuri C047,P045AsikZehra P213,P214,P246AslanGülnur P024AtaMelekTunç P217,P219AtabeyNese P069AtaeeAmin C092AtaeeRamin C035,C092AtaieAmin C035AtturSreeja P252AvşarİbrahimSerkan P223,P225AyBedirhan P062,P148AyErtan P223AycanYererMukerremBetul P265AydemirIşıl P062,P148AydemirSamet P243AydınKurçMine P169,P170AydınMehtap C110AydınMelikeÜlkü C109AydınNazan P223AydınSüleyman P010AydınoğluFatma C028AydinMehtap C054AydinSule P093,P107,P108AydinSuleyman P110AydinVolkan C052AydinkarahalilogluNigarDemet

C059

AydinogluFatma C098AyerAhmet P205AyhanBeycanGözde P204

AyhanGozde C108,P213,P214,P245,P246

AyhancıAdnan C099AykacEmel C059AynacıoğluAhmetŞükrü P223AyoJosephO P114BabaoğluMelihÖnder P227,P228,P229BabaoğluUlkenTunga C060BabuGNagesh P115BaccettiFabio C050BachsaisNassrine P231BaciarelloMarco P188BackmanJanneT P189BademOzge P243BaderMarva P177BadíaJosefa P162BadurIsa P201BagciSengalTaylan C093BagcivanIhsan C017BahadirAcikaraOzlem P268BahcivanEmre P091,P092BahtiriElton C105BaiskhanovaDinara P105BajajHarishKumar C063BakhoucheHana C051BakytgulYermekbayeva P161BalNurBanu P025,P026,P034,P035BalázsfiDiána P002BalcıHakan P103,P250BaldomàLaura P162BalogluEmel P009BaranyiMária P002BarbarossaAndrea C080,C081BarisonAndersson P151BarjaktarovicIva P263BaroneAdesiFrancesco C050BarutBurak P077BasgutBilgen P160BatistaAlineCarvalho P016BayirYasin C096BayramBaşak P235BayramRecep P149BayramZeliha C074,P182,P199,

P200

68

AUTHOR INDEXBeckaertVirgile C003BegimbetovaDinara P105BeitnereUlrika P144BeköKatinka P097BektasRima C080,C081BektasTurkmenNurcan P093BektaşEmine P119,P145BellidoInmaculada P179BensehailaSarra P072BenterIbrahimF P252BerettaGiangiacomo P051BerkBarkın C057,P187,P212,

P243,P244BerközMehmet P113BerktaşFatih P129BermudezBeatriz C008,C015BetovaTatyanaMarinova P075BettschartWolfensbergerRegula

C080,C081

BezerraDanielPereira P151,P262BibliSofiaIris P042,C029,C011BiessenErikA.l. C015BigaTeodora P251BilgeS.Sırrı P237,P078,P103,

P250,P090BlahaJan C051BlancoEncarnación P179BlancoRaquel P270BlazhevAlexaderBozhidarov P075BolatMustafaSuat P078,P090BolukbasiNermin P192BolukbasiOkan P192BomfimLarissaM. P262BondarevVladimir C004BonnetDominique C003BoroduskisMartins C086BotzBálint P097BoubayaLilia C024BoukhalfaAbibHinda P261BoussagAbibLila P231BoydensCharlotte P017,P018BozkurtAtilla P223,P227,P228,P229BozkurtAyhan P237,P103BozkurtEzgi P149

BozkurtOzan C097BozkurtTurgutEmrah P059BraberSaskia P166BrasseDavid C003BroersenLaus C065BrouckaertPeter C011BuharaliogluCuneytKemal P011BuistHomanManon P271BuldukMehmet P021,P248BulutAksoyHacer P195BurulBozkurtNihan P141BuyukBasak C096BuyukokurogluMehmetEmin P080,P083,P088BüyüknacarH.Sinem P081ByeonJiYeong P220,P221,P222CabralAnaCristina P015CadirciElif C096,C107,P167CaglayanFeriha P227,P228CakmakEcirAli P006CalSeda P138CamciCelaletdin P153CampbellMary C049CamuescoDeseada C095CanCenk P023CanÖzgürDevrim C067,C068CanVediaC P005CanbolatFadime P190CandanIbrahimAydın P241CansevMehmet P063CaramonaMargarida P015CarcakNihan P135CarlssonJens C030CarneroManuel P029CasaresPorcelManuel P163CassambaiShabana P236CastagnéVincent P067,P117CastelBrancoMargarida P015CattıkBusraNur P212CavolliRaif P051CavusogluIrem P086,P087CebotarencoNatalia P178CedazoMinguezAngel P141CelikJaleBengi C087

69

AUTHOR INDEXCelikyurtIpekKomsuoglu P121,P122CengelliCigdem P107,P108CengizBeyhan P153CenikBaşar P033CercasElena P054CetinDamla C107CevikLokman P227,P228CevikOzge P232CeylanCengizhan C057,P243,P244CeylanIlayda P181ChagasAlexandreDaSilveira

P073

ChahdouraHassiba P272,P273ChandaAnurag P152ChandrasekharBindu P252ChastreEric C024ChatzianastasiouAthanasia P039,P042ChawlaSumir P036ChenTingJui C064ChingFidelisPoh C089ChoHeaYoung P215ChristieMacdonaldJ C002ChristodoulouEirini P039ChuecaNatalia C095ChungWenHung C064CicekMesut P040CicekMuhammedMucahit C017,C018,P154,

P155CiftciOsman P139CilakerMiciliSerap P076CinarIrfan P167CinarSuzan C032CirovicSanja C025CivelekErkan P048,P049CoelhoNunoRamos C058CokkinosDenis P038ColladoAida C005,C044,P052CompagnoneChristianAngel P188CorreiaDeSáPaulo C021CorumOrhan P091,P092CostaCinaraO.D´sousa P262CostaCinaraOliveiraD`sousa

P151

CostaEmmanoelVilaça P151

CoşkunseverDeniz P104CrunelliVincenzo C036CsípöTamás P014CumbulAlev P032CurimbabaTainanFreitasSalmeron

P073

CzikoraÁgnes P014ÇağlayanDumanNesrin P204ÇakmakAyça P010,P110ÇarçakYılmazNihan C036ÇavuşoğluTuğba P062ÇavuşoğluTürker P023ÇeçenYiğit P158ÇelenkFatmaGül P023,P104ÇetikSongül C099ÇetinelŞule C013ÇevikÖzge C013ÇınarElif C037ÇınarÖnder P090ÇiçekEkrem P242ÇiçekMesut C014ÇolakOrayNeşe P235ÇoşkunseverDeniz P023DaSilvaLeandroAntero C039DacanayAleth C088DaciArmond P047,P051DagostinoConcetta P188DagtekinNurdan P048DağdevirenBirsenHarun P242DaiberAndreas P042DalkılıçBaşakDuman P239DalkırFatmaTuğçe C028DambrovaMaija C048DanchevaVioletaYordanova P075DarakcıÖzge P237DaubeufFrançois C003DavidFrancois C036DayarEzgi P069,C097DeAlmeidaCostaCelsoAcácioRodrigues

P073

DeAlmeidaJúniorLuizDomingues

P073

DeJagerWim P007DeKivitSander C006

70

AUTHOR INDEXDeLaSernaSofia P030DeTheijeCarolineGm C065deWaardCindy C066DeanSadie P236DelRosarioMonica C088DemeterKornél P002DemirAhmetTuran C100DemirBülent P043,P044,P124,P226DemirDoraDevrim P182DemirMehmet P082DemirOmer P069DemirÖzkayÜmide C067,C068DemirUfuk C091DemirelYılmazEmine P025,P026,P033,

P034,P035DemirkilicUfuk P046DemirkolKübra P102,P129DemirtasSahinTugce P019,P068,C104DemiryurekSeniz P153,P060,P006DemiryürekAbdullahTuncay C077,P006,P060,

P153,P218,P225DemiryürekŞeniz C077,P218,P225DemistasSahinTugce C022DénesÁdám P097DenizGunnur C032DenizaltıMerve P056DenizaltiMerve C020DereliYüksel P031DericiMehmetKursat P033DermanSerap P266,P267DeschildreCatherine C024DiStasiLuizClaudio P073DiYaqi P123,P125DiasClaraGonçalves C058DíazChicoJuanCarlos P270DíazChicoNicolás P270DikBurak P091,P092DinçBora C023DiogoLucíliaNeves C058DivsalarDorsa P014DiyarbakirBusra C107DjanicMaja P263,P070DjokicVladimir C025,C062DoanThinh C031

DobrevMiroslavLyubenov P064DodiyaHemrajB C106DoganciSuat P046DoğantürkZekiye C077DokumacıAlimHüseyin P175,P176,P265DolunayAbdurrahman C016DomaniewskiTomasz P180DomingoElena C044,P052DonertasBasak P107,P108DongFang P058DongShifen C027,P066DoranFigen C103DrososChristos P202DuarteJuan C070,P053DuhlenskiIliyaIvov P064DumanIbrahim P159DumanIpek C093,P031DumanMineKadıoglu P079DumanNesrin C108,P213,P214,

P245,P246DumanSoner P023DunnWilliamR P041DurakMehmetAkif C111DurluKandilciNezahatTuğba P020,C057DurmusNergis C069,P097DurnevAndrey P050DursunErdinç P044DutraLíviaMacedo P151DuvalClarisse P067DuvanAydemirKubra P099DuvanIbrahim P046DzirkaleZane C086,P144EbilogluTurgay P084EfeOğuzhanEkin P138EfentakisPanagiotis P038,P039EgliteJelena C086EidAliHussein C120EkemenEmine P129EkiciKemal P156EkinSuat P248ElHashimAhmedZ P252ElNebrisiEslam P008ElibolBülent C037ElkashabSahier P258

71

AUTHOR INDEXElmasSait C091,C119EmersonMichael C043,C055EmlakcıoğluEmelC. C079EmreMustafa P096EnginSeçkin P077EnrightDuncan P178ErAyse P091,P092ErcanFeriha P032ErdalAğrıArzu P078,P237,P250ErdalMehmetEmin P223ErdemSabanRemzi P138ErdemirFikret P078,P090ErdenFaruk P080,P083,P088,

P118,P119,P121,P122,P145

ErdinçLevent C046,P020ErdinçMeral C046,P020ErdoganCem P187ErdoganEsra P256,P257ErdoganMehmetAli C111ErdogmusSerap P003ErdoğmuşÖzgenZeynep C020,P046ErenMehmet P203ErenlerRamazan P275ErerBurak C033ErfanGamze P169ErgulMerve C017,C018,P154,

P155ErgurBekirUgur C047,P238ErgürhanKıroğluOlcay P234ErinNuray P157,P158,P164,P165ErkoseogluIlknur P079,P086,P087ErmisErkan P138ErmisHilal P065ErogluZuhal C053ErolKevser C060,P089,P107,

P108ErtaçSerdarSelda C094ErtinIsmetHande P100EryigitTugba P135EscuderoPaula C005,C044,P052EserHatice P091,P092EserNadire P081EstévezBraunAna P270

EtikanIlker P160FaberKlassNico P271FábregaMaríaJosé P162FanelliGuido P188FangFang P123,P125FaragAhmad P258FarajianMashhadiFarzaneh P150FarmakisDimitris P038FatehiFarangis C042FatemiIman C042FényiAnett P014FerkPolonca C056FernandezLlimosFernando P015FernándezPérezLeandro P270FerrajoloCarmen C050FerreirinhaFátima C021FeuringMartin C061FıratFatih P078,P090FigueiredoIsabelVitória P015FilipovicMilos C043FinkenstadtRandBarbel C031FisslthalerBeate C011FlemingIngrid C011FolkertsGert P166ForoozandehForoozan P150FrancesconiPaolo C050FrossardNelly C003FülöpGábor P014GalvãoAlexandreF.C. P262GálvezJulio P070,C074,C095,

P162,P163GalziJeanLuc C003GarciaAlonsoMauricio P030GarciaBouzaMonica P029GarciaFederico C095GarridoJose P074GarridoMesaJose C095GarridoMesaNatividad C095GarssenJohan C006,C065,C066,

C106,P166GazioğluElifNur P077GazzardBrian C055GelalAyse P195,P196GencAsenaAyse P199,P200

72

AUTHOR INDEXGencerAynur P101GeropoulosGeorgios P202GettingStephenJ P005GezenAkDuygu P043GezerİlknurAlbayrak C078GiacchettiSylvie C031GiachettiSylvie C032GidenerSedef P069,C097GiménezRosa P162GiniRosa C050GiorgianniFrancesco C050GiotiKathrine P038GocmezSemilSelcen C022,C104,P019,

P068GojkovicBukaricaLjiljana C025,C062GokSule P190GokceGoksel C047GoktasMustafaTugrul C114,C115,C116,,

P174,P227,P228GolocorbinKonSvetlana P070GómezCaravacaAnaMaria P074GomezIngrid C024GomezLuqueAurelio P179GonzalesCorreaJoseAntonio

P030

GonzálezCruz C005,P052GonzálezPonceHersonAntonio

P271

GonzálezTejeroMaríaReyes P163GorenZafer C108,P213,P214GosensReinoud P007GöçmenCemil P081GökŞule P223GökselSibel P023GöktaşMustafaTuğrul C078,C079,P229GölöncsérFlóra P002,P126GörenMehmetZafer P204GriecoPaolo P005GroeninkLucianne C066GruenenfelderFredrik C061GudenDemetSinem C016,P011GudermannThomas P003GuerraBorja P270GuillaumePhilippe P067

GulAhmet C033GulyayevAlexander P106GulyayevAlexandr P276GumusBusra P266,P267GumustekinMukaddes P076,P196GunduzOzgur P120,P099,P100,P101GuneliEnsari P076GunerSahika C082GuptaMayuri P211GurgorPinarNaile P257GursoyNevcihan C100GusdinarTutusGusdinar P095GuzelEsra C101GuzelogluMehmet C047GülaySedat P177GülhanRezzan C108,C109,P204,

P213,P214,P245,P246GültekinFatih P241GümüşlüEsen P118GündoğduArslanDeniz P103,P237GündüzEsra C113GündüzÖzgür P127GündüzReyhan C077,P218,P225GüngörBuket P199,P200GüngörCengizhan P112GürayTülin P033GürdalHakan C082,P191,P239GürelAyşe C113GüreşirMustafa P022GürsesCilaHacerEsra C113GüzelHasan P103HabibAlaaHamed P041HaginaElvira C086HaliciZekai C096,C107,P167HallerJózsef P002HanSevtap P025,P026,P034,P035HanedanBülent C093HarveyKatherineL P236HashadYasser P258HassanshahiGholamhossein C042HatipoğluÖmerFaruk C113HazarAyşeNur P132HazimAmmarImad P259HaziriLiridon C105

73

AUTHOR INDEXHeinleHelmut C025,C062HelyesZsuzsanna P097HerkenHasan P223HermanowiczJustynaMagdalena

P180

HıdıroğluSeyhan C109HibertMarcel C003HirayamaYutaka P264HocaogluNil C097HoffmannCarsten P003HorváthGergely P097HowarthFrank P008HowarthLuke P008HoxhaRexhep C105HungShuenIu C064HuseynovaLeman P121,P122HussainAfthab P236IkbalBarışIşık C009IlgazYasin P256,P257IlhanMustafa P171,P172,P173IlkayaFatih P103ImlachWendyL C002IonovaEkaterina P050IsaHamza P114IsitenHavvaNuket P190IskitAlperBektas C094,P171,P172,

P173IslamiHilmi C105IsliFatma C054ItkonenMattiK P189IvanovViacheslav C004IvanovaNinaEmilova P064IyigunTaner P048IzolVolkan P253,P254,P255İbişoğluBurçin C085İdrisoğluGülçebiMedine C108,P135,P204,

P213,P214,P245,P246JampolskaMonika P098JansakulChaweewan P012JansenSeppR. P007JansoneBaiba C086,P144JaramilloJuárezFernando P271JeninaJoanna C086JerenecKatja C056

JeurinkPrescillaV. P166JiménezAlonsoSara P270JimenezRosario C070,P053JinMing P057,P058JocaSamiaR.L. P116JohnTheresaAdebola P230JordãoJulianaBahiaReis P016JovanovicDjuraskovicMirjana

P251

JoyceKrystyna P178JukevicaKatrina C086JurisevicNika C083JurjevicIvana P134JuwitaTanti P184K.ÇelikyurtIpek P118KabasakalLevent P232KacanMeltem P011KaczynskaKatarzyna P098KadıoğluDumanMine P077,P086,P087KadiEsma C110KadolglouNikolaos P039KadyirbekovnaZhaznayevaZhanat

P019

KahramanErkan P069KakazanisZachariasIoannis P039KaleŞule P157,P158KaleliDurmanDeniz C009,P048,P049KalkanFerhat P085KalkanSule P238KalkışımSaid C079,P229KalyoncuNuriIhsan P079,P086,P087KamilovFelixKh. C090KanokwirunKanyanatt P012KapanidisKonstantinos P094KaplanHalilMahir C103,P001,P004,

P233,P234,P240,P253,P254,P255

KapoukranidouDorothea P094KaptanEngin C032KaraCüneytOrhan P216,P224KaraErkan C097,P069KaraHalil C078KaraalpAtila C108,P214,P246,

P245,P204,P213

74

AUTHOR INDEXKarabacakKubilay P046KaraboğaArslanAyşeKübra P175,P176,P265,P269KarabulutEnes C026KarabulutErcan P004KaracaOzgur P227,P228KaradağÇetinHakan P120,P127,P128KarakoçMetinDeniz P216,P224KarakulakÇağla P124,P140,P210KarakusEmre C096KaralıNilgün C112KaramanMeral P076KaramanYasemin P059KaranTunay P274,P275,P249KaraomerliogluIrem C012KaratasKocberberEmine C057,P187,P212,

P243,P244KaratasOmerFaruk C101KarkTamás P014KasMartienJ C065KasapcopurOzgur C033KasvikiPaschalina P193,P206KayaAyşeDemet P169,P170KayaEngin P084KayaErkan P046KayaHavva P118KayaMeryemŞeyda C046,P020KayaYesim P059KayacanNurten C023KaygisizBilgin P089,P107,P108KayıkcıogluMeral C053KaykiMutluGizem C012KazkayasiInci P141KeleşRümeysa P132KelleIlker C046,P020KennedySimon P028KenzhebayevaNuriya P276KerperienJoann C006KerryZeliha C072KeshavarzianAli C106KesiciOktay P238KesimMuratSabri P079KesimSabriMurat P086,P087KeskinCumali C099KeskinIlknur P268

KeskinUlya P138KhalimovAlmazR. C090KhaliullinFerkatA. C090KhassenbekovaZhanagul P106,P161KılıcMehmet P027KıroğluOlcayErgürhan P096,P102,P129KıvılcımManolya P160KızılaslanDeniz P187KibarYusuf P084KilincIbrahim C114,C115KimDongHyun P220,P221,P222KimSeHyung P220,P221,P222KimYoungHoon P220,P221,P222KirazAslı C091,C119KiremitciSaba P035KirmiziNerimanIpek C054,C110,P181,

P268KirogluArzu C052KishorKamal C118KittelAgnes P126KleczkowskaPatrycja P098KlusaVija P144KnippelsLeonM.J. C006,C066KocaHalitBugra P109KocaTulay P061KocacaliskanIsmail P266KocyigitBusraSumaye P266,P267KoçoğullarıCevdet P203KogutEwelina P098KohEunJee C030KojicVesna P263KolikLarisa P050KopeckyJiri P186KorcumAylinFidan P158KorenarskaSabieIbrahim P064KorkmazBelma P011KorkmazCeren C047KortunaySelim P216,P217,P219,P224KorucuFatmaCeyda P128KorunZeynepEce C022KoselerAylin P216,P217,P224KostadinovaAtanaskaI C006KostomitsopoulosNikolaos P038,P039KotelevetsLarissa C024

75

AUTHOR INDEXKouvelasDimitrios P094,P202KoványiBence P097KoyuncuogluCenkerZeki C054,C110,P181KozhakhmetovSamat P106KöksalAkkoçMeriç P177KörnyeiZsuzsanna P097KöseAkif C109KösemehmetoğluKemal C094KraneveldAlettaD C006,C065,C066,

C106,C166KrasniqiShaip C105,P051KrasniqiValon C105KrastevPlamenKrasimirov P075KrastevaGenkaTsvetanova P064KreuzerJörg C061KryzhanovskySergey P050KrzanMojca C083,P147KukaJanis C048KulsharovaGulsim P105KumarVikas C063KumcuEda P081KurtgozSerkan P109KushugulovaAlmagul P106KutluZerrin C107KutterAnnette C080,C081LackovicZdravko P133LakovaEmiliaTsvetanova P064LamVincentM. C030LapiFrancesco C050LarabaDjebariFatima P261,P231LatifInas P258LeCudennecCamille P067LeeChoongMin P220,P221,P222LeeHyunJee P220,P221,P222LeeJoanne C061LeeSeokYong P220,P221LeeYongBok P215LemosAnaRita C058LeónJavier P270LeusinkMuisThea P166LevendoğluFunda P111,P112LéviFrancis C031,C031LevitaJutti P184Lezoualc’hFrank P007

LiXiaoMei C032,C031LiangYaoyue P066,C027LiapiCharis C041,C076LiepinshEdgars C048LimHyeJin P220,P221,P222LipkowskiAndrzej P098LockeIanC P005LonghitanoYaroslava C040,P072LongroisDan C024LopesDaSilvaSofia C065LopezSergio C008,C015MacielIzaqueDeSousa P116MacitÇaglar C013,C045,P232MacitEnis P247MacleodKenneth P036MagtotoMay C088MairbäurlHeimo P009MakarovaElina C048MakreckaKukaMarina C048MalekiSaniMahdieh P250ManafikhiHusseen C040,P072MancarBusra P212MansorSharifMahsufi P259MansurogluBanu P266,P267MaravicMarina P134MarchandPatrice C003MarchesiniMaurizio P188MarkovicLipkovskiJasmina C025MarquesPatrice C005,C044,P052MartinGregory C088MartínRodríguezPatricia P270MartínezSaldañaMaríaConsolación

P271

MasochaWillias C001MatakIvica P133,P134MavrantoniEvangelia P094MavriJanez C083MaytalmanErkan P096,P102McnaughtonSmithGrant P270MederosYSchnitzlerMichael P003MedinaUrsula P029,P030MeeChristopherJ P236MenezesLeocileyRochaAlencar

P151

76

AUTHOR INDEXMercanogluFehmi C045MercanogluGuldem C045MermerAydin C093MichailidouMaria P194,P197,P207MichailidouStamatia P194,P207MichelJeanBaptiste C024MikhalovskySergey P105MikovMomir P263,P070MillanLinaresMariaC C015MillardLindsey C049MinaminoHideaki P264MinareciEdibe C023MohamadAmr P258MoleroMesaJoaquín P163MollaYalew P168MoniruzzamanAkm C038MontaliArianna P188MonteiroEmíliaCarreira C058MontellaSilvana P188MonteroJuanCarlos P270MontserratDeLaPazSergio C008,C015MorelloJudit C058MorganMaryE C006MoschopoulosNikolaosP. P193,P206MoshageHan P271MostafaHedeabGomaa P258MosyaginViacheslav C004MotaMauricioC.S. P262MuderrisogluAhmet P227,P228MurataevDaniyarZ. C090MurianaFranciscoJ.g. C008,C015MusaMalbora C105MutakinMutakin P184MutluMerve P212MutluOğuz P080,P083,P088,

P118,P119,P121,P122,P145

MutluaySevgiUğur C037MüderrisoğluAhmet C079MüllerChristaElisabeth P097NacakMuradiye P223NacitarhanCahit C074NadorovaAnna P050NaghshNooshin P150

NaiduGangaModi P071NairRenukaR C075NalbantSelvi P023,P104NanjappanSateeshKumar P071NaranjoMariaC C015,C008NarbuteKarina P144NathRajendra C034NediTeshome P168NelsonMark C055NemutluDilara P093NepelAngelita P151NergizYusuf P020NeuvonenMikko P189NeuvonenPerttiJ P189NezicDusko C062NeziriBurim P051NiJian C027NiemiMikko P189NikolovaJoanaRumenova P064NimatoudisIoannis P193,P206NizamEsra P164,P165NorelXavier C024NosahareOtokitiAbrahim C089NoskovaPavlina C051NovakLucija P147NovakovicRadmila C025,C062NovicLana P147NtaralasAchilleas P194,P197NurgozhinTalgat P105,P106NurulainSyed P008NurullahoğluAtalıkKısmetEsra

P022,P027

NurullahoğluZ.Ulya P027NusretDalÇağatay P111O`valleFrancisco C070ObayashiYoshiyuki P264OdabasiGulPelin C010OgulenerNuran C098OguzElif P060OguzFatih C010OğuzElif C077,P218,P225OkumusSeydi P006OkyarAlper C102,C031,C032,

P185

77

AUTHOR INDEXOlaleyeTosinMaxwell P146OlefirYury C004OliveiraDaSilvaAndersonManuelHerculano

P073

OlowolafeOluwatayoBenedict

P146

OlukmanMurat P023OnalIbrahimOzkan C087OnatFiliz C036,C108,P135,

P204,P213,P214,P245,P246

OnayBesikciArzu P040OozeerRaish C066OsmanagaogluMehmetArmagan

P086,P087

OtoGokhan P021,P248OtrokocsiLilla P126OuadiAli C003OvalıMehmetAkif C091OyedejiAdebolaOmowumi P146OyemitanIdrisAjayi P146OzMurat P008OzakcaIsil P040OzbekArasogluTulin P266,P267OzbekHanefi P268OzcanAyhan P084OzcanGulnihal C059OzdemSadiS. C074OzdemSebahat C074OzdemirHulya P021,P248OzdoganHuri C033OzenGulsev P047,C024OzenKücükcetinIkbal C074OzenMustafa C101OzenSerkan P156OzerAli C111OzerCuneyt P019OzerErdemKamil C114,C115,C116,

P171,P172,P173,P174OzerMuratAtabey P156OzgurHakan C072OzhanOnural P082OzhanOnurhal C111OzilhanSelma P190

OzisSalihErpulat P040OzkanAhmetSelim C111OzkanPelin P196OzkaramanAyse C060OzkayaMesut P060OzkulaSongul C108,P213,P214,

P246OzlerAhmed P243OzsarlakSozerGonen C072OztasEmin P256,P257OzturkDilek C032,P185OzturkEbru P265OzturkGozde C071,P061OzturkNarin C031,C032,P185OztuzcuSerdar P006,P060,P153OzunalZeynepGunes P208ÖğülenerNuran C028ÖksüzErsoy P248ÖlmezErcüment P062ÖnalAytül P104ÖnalBurak P043,P044,P124,P226ÖnalÖzkan P112ÖncelÇağatayHilmi P217,P219ÖncüMeral P242ÖzakcaIsil C014ÖzatikOrhan P089ÖzatikYasemin C060,P089ÖzçelikayArifTanju C014,P040ÖzdemirAysun C085ÖzdemirHoxhaBirgül P127ÖzdemirMikail C109ÖzelArzu P077ÖzenDeniz P226ÖzerErdemKamil C078,C079ÖzerMehmetKaya P241ÖzerbilÖnderMurat P111ÖzkanŞeyma P219ÖzkulaSongül P245,P204ÖztopuzÖzlem C091ÖztuzcuSerdar C077,P218,P225ÖztürkÇimentepeÖzge P081ÖztürkEbru P175,P176,P177ÖztürkTülün P148ÖztürkYusuf C067,C068

78

AUTHOR INDEXÖzünalZeynepGüneş P143,P209ÖzyazganSibel P043,P044,P124,

P140,P226ÖzyazıcıTuğçe P177ÖzyönGözde P191,P239PalRishi C034PalaKaraZeliha C032,C102,P185PalmeryMaura C040,P072PamukcuBurak C045PandiellaAtanasio P270PantKamleshKumar C034PapaioannidouParaskevi P193,P194,P197,

P206,P207PapapetropoulosAndreas C011,C029,P038,

P042,P056PapazisisGeorgios P202ParissisJohn P038ParlakpınarHakan C010,C111,P065,

P082,P085,P156,P139ParlarGurkanAyse P205ParthasarathySuhanya P259PascualRhemcee C088PatacsilJarrah C088PatetkoLiene C086PauwelsBart P017,P018PavlovicNebojša P070,P263PawlakDariusz P180PawlakKrystyna P180PazarcıPercin P233PeiróConcepción P054PektasAyhan P109PektaşMehmetBilgehan C071,P061,P109PelletierJulie C021PelusoIlaria C040,P072PengYuanyuan P058PereiraSofiaAzeredo C058PerezPardoPaula C106PericMiodrag C062PilanciKezbanNur C102PilipenkoVladimirs P144PiquerasLaura C005,C044,P052PizzimentiValeria C050PleñosMay C088

PolatAlaaddin C010,P065,P082,P085,P156

PolatNihat P156PoluzziElisabetta C050PoppelaElga C086PórszászRobert P014PortoHellenKarinePaes P016PotnuriAjayGodwin C075PourzitakiChryssa P094,P202ProdanovicOlivera P251PryczyniczAnna P180QorrajBytyqiHasime C105QuaglioAnaElisaValencise P073RahmanlarHanife P143RajkovicJovana C025,C062RalevicVera P041RamadhaniSelma P184RamajoMarta P029,P030RamanathanSurash P259RamataStundaAnna C086RamosGonzalezMariella P054RauziFrancesca C043ReardonDeborah C061ReelBuket C047ReggiRaffaella C040,P072ReguilloFernando P029,P030ReljaMaja P133,P134RemirezDiadelisDiade C069ResstelLeonardoBarbosaMoraes

C039

RezansoffStefanieNadya C038RiddellAlexandra P028RincónSanchezAnaRosa P271RiusCristina C044,P052,C005RobertoGiuseppe C050RoblesVeraIñaki C070,P053RochaMatheusLavorenti P016RodriguesAnaCarolinaBorgesDaCruz

P151,P262

RodríguezAlba P074,P162,P163RodríguezCabezasMaríaElena

C095,P163

RodríguezDavid C030RodriguezMariaElena P074

79

AUTHOR INDEXRodriguezNogalesAlba C070,C095RomagnoliNoemi C080,C081RomeroMiguel P053,C070RoncadaPaola C080,C081RosaJessica C039RozkiewiczDariusz P180RumaksJuris P144SabioJoseMario P053SadanGulay C023SadiGökhan C071,P033,P035,

P061SaduakhasovaSaule P106SaeedMazen C047SafranNurhas C045SagindykovaBayan P276SagirMustafa P065,P139SaglamMerve P079SaglamSezer C102SağırMustafa C010SağlamEsra P223SahanFiratSeyhan C016,P011SahinAynur P235,P238SahinAyseSaide P031SahinDuygu P045SahinErdemliInci C020,P059SahnaEngin P024SahuRoshanKumar C118SakaEsen C037SakulAyşeArzu P268SalahpourAli C030SalehAlaaeldin C120SalesAmandaJuliana P116SalievTimur P105SalimiSaeedeh P150SaltalıAli P112SaltaliAliÖzgül C087,C093SaltanGulcin P268SamorodovAleksandrV. C090SanHipólitoLuengoAlvaro P054SanPedroPrescilla C088SancarBasSerap C032SánchezFerrerCarlos P054SanchezManuel P053SandıkçıYüksel P217,P219

SangXuxing P123,P125SantoFelipeRosárioDoEspirito

P151

SantosTiagoR. P262SanzMaríaJesus C005,C044,P052SaptariniNyiMekar P095,P184SaraMehmetYildirim P136SaracBulent C017,C018,P154,

P155SaracalogluAhmet P153SardeliChrysanthi P202SargonMustafaFevzi C087SariAyseNihal P011,C016SayınBetül P209SazBahattin P181SchmidtJan C056SchmidtMartina P007SchoofNils C061SegosDimitrios C076SeguraAntonio P074SenerBilge P153SenerGoksel P232SengulEmin C107SenolSefikaPinar C016,P011SergazyShynggys P013,P106,P161,

P198,P276SergazykyzyMustafaRauan P019ServeraEmilio C005,P052SevcenkoMarija C100SevgiSerhan C033SévignyJean C021SevinGulnur C072,P045SeyahiNurhan P210SeyrekMelik P046,P084,P247,ShabalinaYuliyaV. C090ShahzadiAndleeb C026,C101,P124,

P140,P210ShakiFatemeh C035ShamsizadehAli C042ShariatmadariRayhaneh P137SharifzadehMohammad P137SharmaManju C063ShayestehYaghub C035ShiJiachen P066

80

AUTHOR INDEXShibeshiWorkineh P168ShulgauZarina P276SigalaFrageska P038SilvaFelipeMouraAraujo P151SilvaIsabel C021SilvaRamosMiguel C021SilvaThiagoB.C. P262SingerJackW. C049SlanarOndrej C051SmetanovaLibuse P186SmythErica C043,C055SoaresMilenaBotelhoPereira

P151,P262

SomersJulianMyles C038SoniHitesh P230SonmezIkbal C101,P210SorokinaAlexandra P050SotoKarina C058SözmenEser P023SperlághBeáta P002,P097,P126StanimirovBojan P070,P263StankovKarmen P070,P263StasinopoulouMarianna P039StavrevaGalyaTzvetanova P075StolyarukValery P050StorchUrsula P003StrilakouAthina C041SukurogluErkan P227,P228SuleimanMuhammedM P114SulejczakDorota P098SumayaMartínezMaríaTeresa

P271

SunJianning P066,C027SunYikun P066SuñgaShannen C088SupuranClaudiuT. C112SurazynskiArkadiusz P180SuterThomas P038SvetlikSvatopluk C051SvobodaZbynek P186SzaboCsaba C011,C029,P042SzalaiAndrea P014SzklanyKirsten C066ŞahinCeren P132

ŞahinHasan C119ŞenSelçuk P142ŞenerGöksel C013ŞentürkRecepSelim P104ŞentürkSelim P023ŞimayYaprakDilber C085ŞimşekTuncer C119ŞingirikErgin C103,P001,P004,

P233,P234,P240TaburSuzan P060TadesseGetachew P168TahirbegolliBernard C073TakırSelçuk P037TalgatNurgozhin P013,P161,P198,P276TalhaouiNassima P074TanLi P057,P058TanerNeda C057,P212,P244TankiewiczKwedloAnna P180TanröverGamze P165TanyeliÖmer P031TanyeriMehmetHanifi P080,P083,P088TanyeriPelin P080,P083,P088,P118TarhanNevzat P190TasSadikTaskin P136TastekinEbru P120TauheedMuhammed P114TaylanSengalBagci C087TejerinaTeresa P029,P030TekinGözde C013TekinMurat C119TekinSatıZeynep C091,C119TekmenIsıl P076TelBanuCahide C037TemizEbru P153TemizReşitoğluMeryem P011,C016TentaRoxane P038TerzioğluBebitoğluBerna P203TerzioğluDuygu C009TeskinÖnder P047,P048,P049,P055TetikVardarliAslı C053ThaçiKujtim C105ThijssenSuzan P166TiftikRukiyeNalan P159TireYasin C093

81

AUTHOR INDEXTiwariPrafullaChandra C034TokerAysun P174ToktayErdem C096,P167TonyalıHüseyin P142TopalGökce C024,P047TopalTurgut P257TopcuAtilla C096ToprakAyça P037TopuzBulent P224TopuzBülent P216TopuzRuhanDeniz P120,P127ToralMarta P053,C070TornioAleksi P189TóthAttila P014ToyHatice P031TrifiròGianluca C050TsaousiGeorgia P094,P202TsorinJoseph P050TuğluMatildaMerve P191,P239TuncokYesim P196,P235,P238TunctanBahar C016,P011TuranNazlı C067TuranOzge C071TurfanOrhan P082TurganAşıkZehraNur P204,P245TurganZehra C108TurgaySoner C033TurgutNergizHacer C017,C018,P154,

P155TurgutSebahat P217,P219TuyluYusuf P006TürkayCengiz C074TürkkanAsibe C109TürkönHakan C091TürkyılmazMesut P063UchiyamaAkira P264UckuReyhan P195UçarYılmaz P081UganRustemAnil P167UgurluSerdal C033UgusmanAzizah P028UğurMeteGürol C077,P218,P225UğurMurat P203

UlakGüner P080,P083,P088,P118,P119,P121,

P122,P145UlasliMustafa P153UlianaDanielaLescanoMartins

C039

UludağOrhan P025,P026,P034,P035UlugölAhmet P099,P100,P101,P127UlupinarEmel P107,P108UlusoyAyşe C037UlusoyKemalGökhan P046,P084,P247UmaSerdar P141UmmanBerrin C073UnsalDemet P011UpiteJolanta P144UrasovaMaira P106UsanmazSuzanEmel P025,P026,P034UsluÜnal P032UtkanTijen C104,P068,P019,

C022UtrillaMaríaPilar C095,P163UtrillaPilar P074UyanıkgilYiğit P023UyarEmre C046UyarHasan P248UyarImran P047UydeşDoğanBirselSönmez C009,C024,P037,

P047,P048,P049,P055UysalPalaÇiğdem C119UzunHafize C045UzunÖzge P149UzunogluDeniz P267ÜlkerSibel P104ÜnIsmail P159ÜnalGökhan P132ÜresinYağız P142,P208VallejoSusana P054ValsamiGeorgia P039VandeVoordeJohan P017,P018VanDerHorstHilma C065vanLimptKees C066VanRynJoanne C061vanStaverenNienkeG. C066vanWageningenTheclaA. C066

82

AUTHOR INDEXVandenDaeleLaura P017,P018VarAhmet P062VardıNigar C111VarelaAimilia P038VelimirovicJelena P251VelineniKalpana P009VelioğluÖğünçAyliz P032VellucciCarlotta P188VenskutonisRimantas P072VerdouwMonika C066VerheijdenKimA.t. P166VezzaTeresa P074,C095,P163VillanuevaJose C088VilskerstsReinis C048VititnovaMarina P050VolgemutZiga C056VolskaKristine C048VuralKamil P062,P148WangLin P057WangRan P123,P125WangXiaomin P260WangYu P058WhitemanMatthew C042,P043,P055WibowoMarliaSinggih P095WillemsenLinetteE.m. C006,P166WinterMichaela P003WoodMarkE C043WoodsDavid P178WopereisHarm C066WuJiangbo C065WuYan P057XueChangjiang P058YalcinAyfer C045YalçınÇakmaklıGül C037YalınSerap P113YamakoğluSelin P055YamantürkÇelikPınar C073,P142,P143,

P209YangLin P260YangSusanKeunHang P008YaqubovKamandar P130YarışErsin P079,P086,P087,P223YarwoodStephenJ. P007

YaşarÜmit C078,C079,P223,P227,P228,P229

YaylaMuhammed C096,C107YazarEnver P091,P092YaziciZeliha C026,C101YeganiArashAlizadeh P004,P096,P102,

P129,P233,P234,P240YelkenciGozde P266YenilmezEngin P086,P087YererAycanMükerremBetül P175,P176,P269,P177YesilSemen C045YesiltepeMetin P136YeşilotŞükriye P241,P242YeşilyurtMurat P170YetikAnacakGünay C072,C097,P045,

P055,P069YıldırımMetin P113YıldızAkarFüruzan P080,P083,P088,

P118,P119,P145YıldızOğuzhan P247YıldızYasin C109YılmazBayhanDilek C009YigitaslanSemra C060YigitbasiTurkan P268YiğitaslanSemra P089YildirimEngin P107,P108YildirimOnurGokhan P109YildirimSahin C018YildirimVedat P046YildizOguzhan P084,P046YilmazEmineDemirel P021YilmazSercan P084YorsinSomruedee P012YusufPeterO P114ZadaWahid P131ZaimoğluAyşenur P237ZajacDominika P098ZangBaoxia P057,P058ZanzaChristian C041,P072ZarinaShulgau P013,P198ZeeshanSara P131ZelenaDóra P002ZhanagulKhassenbekova P013ZhangJingquan P123,P125

83

AUTHOR INDEX

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

NOTES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

NOTES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

NOTES

PHARMACOLOGICAL ASPECTS OF MICROVASCULAR CELL-CELL SIGNALLING AND CVS DISEASE21−22 September 2016Oxford, UK

Register & submit your abstract

There has been a dramatic increase in our understanding of cell signalling over the last five years, with key papers indicating the importance of endothelial cell projections as signalling microdomains, which appear subject to disruption by cardiovascular disease. This focused meeting will provide a forum for scientists working in vascular biology, with a particular interest in identifying novel therapeutic targets in endothelial cell dysfunction that is a feature of cardiovascular disease.

For further information about attending or presenting at this meeting, please email [email protected] or visit www.bps.ac.uk/cvs.

Deadlines for your diary:

Abstract submission: 10 August

Early registration: 26 August

Bursaries (available for members of the British Pharmacological Society): 10 August

Documents

TABLE OF CONTENTS - EPHAR 2016 · Plenary Lecture, Hall A (13:30-14:30): Purinergic signaling in adult neural progenitor cell functions: Experimental basis and possible therapeutic